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Abstract
Gene expression data analysis methods that exploit formalized prior knowledge
have expanded significantly in the last 10 years. This thesis explores strategies in
which prior knowledge is used to support the transformation of the original gene
expression data into a so called set-level representation, on which machine-learning
algorithms are applied usually for the sake of predictive classification. The trans-
formation generalizes the input data towards “more abstract” data dimensions that
correspond to various biological functional or structural properties rather than genes.
For example, the original gene expressions may be replaced by activity levels of a
specific set of regulatory pathways, which are estimated from the gene expressions
during the transformation.
We hypothesize that the outlined transformation has positive influence on the out-
come of the subsequent machine-learning experiments due to the following intuition.
Typically, analysis of gene expression data suffers from the well-known “large p, small
n” problem (large data dimension and few data samples) leading to an increased risk
of overfitting. The transformed set-level representation typically has a smaller dimen-
sion, thereby mitigating the “large p” part of the problem. Interestingly, the set-level
approach enables us to address also the “small n” part of the problem, since it al-
lows to merge several gene expression data sets originally using different feature sets
(genes) but unified to the same more abstract units during the transformation. These
two reasons for the suspected boost of the machine-learning performance represent
two hypotheses which are tested as the main contribution of this dissertation work.
We successfully prove that generalization caused by the set-level techniques ex-
ploiting functional relationships among genes of prior defined gene sets allows the
integration of additional data obtained by different platforms or even species, i.e., we
confirm the latter hypothesis. For the former hypothesis, the situation is more sub-
tle. We show that using standard gene sets proposed in state-of-the-art research, the
performance of predictive analysis will not be significantly improved in terms of clas-
sification accuracy. However, we propose some more sophisticated definitions of gene
sets which indeed lead to the improvement of classification. These new definitions
based on a careful analysis of gene-regulatory principles represent another significant
contribution of this thesis, albeit limited to prokaryotes.
A lateral contribution of this work is the designed evaluation framework in which
numerous techniques from state-of-the-art set-level gene expression analysis can be
compared in an unbiased and objective manner, from the point of view of predictive
accuracy. Lastly, this thesis contributed to the development of the public web-based
software tools XGENE.ORG and its successor miXGENE.
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Abstrakt
V posledn´ıch deseti letech dosˇlo k vy´znamne´mu rozsˇ´ıˇren´ı metod pro analy´zu dat
genove´ exprese vyuzˇ´ıvaj´ıc´ıch apriorn´ı znalosti. Tato pra´ce zkouma´ strategie ve ktery´ch
jsou tyto znalosti vyuzˇity k podporˇe transformace p˚uvodn´ıch dat genove´ exprese do
nove´ tzv. mnozˇinove´ reprezentace, na kterou jsou aplikova´ny metody strojove´ho ucˇen´ı
za u´cˇelem prediktivn´ı klasifikace. Tato transformace zobecnˇuje vstupn´ı data tak, zˇe
v nove´ “abstraktneˇjˇs´ı” reprezentaci odpov´ıdaj´ı dimenze r˚uzny´m biologicky´m funkc´ım
a struktura´m sp´ıˇse nezˇ jednotlivy´m gen˚um. Naprˇ´ıklad, p˚uvodn´ı genova´ exprese mu˚zˇe
by´t nahrazena aktivitami specificke´ mnozˇiny regulacˇn´ıch stezek, ktere´ jsou vypocˇteny
na za´kladeˇ genove´ exprese beˇhem vy´sˇe uvedene´ transformace.
Prˇedpokla´da´me, zˇe uvedena´ transformace ma´ pozitivn´ı vliv na vy´stup experiment˚u
zalozˇeny´ch na aplikaci algoritmu˚ strojove´ho ucˇen´ı na transformovany´ch datech, a to
na za´kladeˇ na´sleduj´ıc´ı zkusˇenosti. Analy´za genove´ exprese typicky dopla´c´ı na velmi
zna´my´ proble´m, ktery´ spocˇ´ıva´ nadbytku meˇrˇeny´ch atribut˚u a nedostatku pozorova´n´ı,
a vede k zvy´sˇene´mu riziku prˇeucˇen´ı. Mnozˇinova´ reprezentace z´ıskana´ pomoc´ı zmı´neˇne´
transformace ma´ typicky mensˇ´ı dimenzi, tud´ızˇ umozˇnˇuje zmı´rneˇn´ı te´ cˇa´sti proble´mu,
ktera´ spocˇ´ıva´ v nadbytku meˇrˇeny´ch atribut˚u. Je rovneˇzˇ pozoruhodne´, zˇe tento
mnozˇinovy´ prˇ´ıstup umozˇnˇuje rˇesˇit i druhou cˇa´st proble´mu spocˇ´ıvaj´ıc´ı v nedostatku po-
zorova´n´ı, protozˇe umozˇnˇuje slucˇovat datasety reprezentovane´ pomoc´ı r˚uzny´ch mnozˇin
atribut˚u (gen˚u), ktere´ je ale mozˇno sloucˇit na u´rovni aktivit abstraktneˇjˇs´ıch jednotek
zavedeny´ch beˇhem transformace. Tyto dva d˚uvody pro prˇedpokla´dane´ zvy´sˇen´ı vy´konu
metod strojove´ho ucˇen´ı odpov´ıdaj´ı dveˇma hypote´za´m jejichzˇ testova´n´ı prˇedkla´da´me
jako hlavn´ı prˇ´ınos te´to disertacˇn´ı pra´ce.
V te´to pra´ci u´speˇsˇneˇ ukazujeme, zˇe generalizace zp˚usobena´ pouzˇit´ım mnozˇinovy´ch
transformacˇn´ıch technik vyuzˇ´ıvaj´ıc´ıch funkciona´ln´ıch vztah˚u mezi elementy prˇedem
stanoveny´ch mnozˇin gen˚u umozˇnˇuje integraci dodatecˇny´ch dat z´ıskany´ch pomoc´ı
r˚uzny´ch platforem cˇi dokonce zˇivocˇiˇsny´ch druh˚u, cˇ´ımzˇ tedy potvrzujeme posledneˇ
uvedene´ hypote´zu. U drˇ´ıve jmenovane´ hypote´zy je situace trochu slozˇiteˇjˇs´ı. Ukazu-
jeme, zˇe prˇi pouzˇit´ı standardn´ıch genovy´ch mnozˇin, prˇedkla´dany´ch v nejnoveˇjˇs´ıch
vy´zkumny´ch prac´ıch, nen´ı vy´kon prˇi prediktivn´ı analy´ze vy´znamneˇ pozitivneˇ
ovlivneˇn, co se prediktivn´ı prˇesnosti ty´ka´. Nicme´neˇ v te´to pra´ci navrhujeme
d˚umyslneˇjˇs´ı definice mnozˇin gen˚u, ktere´ vskutku vedou k zlepsˇen´ı prediktivn´ı
prˇesnosti. Tyto nove´ definice zalozˇene´ na d˚ukladne´ analy´ze genoveˇ regulacˇn´ıch
princip˚u reprezentuj´ı dalˇs´ı vy´znamny´ prˇ´ınos te´to pra´ce, ktery´ je nicme´neˇ omezen
pouze na prokaryoticke´ organismy.
Stranou od vy´sˇe uvedeny´ch prˇ´ınos˚u stoj´ı navrhovany´ vyhodnocovac´ı framework
pro objektivn´ı vyhodnocen´ı mnozˇinoveˇ orientovany´ch technik pro analy´zu genove´
exprese, jenzˇ posuzuje techniky z pohledu prediktivn´ı prˇesnosti. Posledn´ı prˇ´ınos
te´to pra´ce je prˇ´ıspeˇvek k vy´voji verˇejne´ho webove´ho na´stroje XGENE.ORG a jeho
na´stupce miXGENE.
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Chapter 1
Introduction
Analysis of whole-genome gene expression data has received attention in the last 15
years within some prominent publications (Golub et al., 1999; Subramanian et al.,
2005; Tusher et al., 2001). The limited amount and immense biological complexity of
the underlying gene expression data led to the idea of set-level analysis, which has also
received attention in recent years (Abraham et al., 2010; Goeman and Mansmann,
2008; Hwang, 2012; Michaud et al., 2008; Mramor et al., 2010; Staiger et al., 2012;
Tarca et al., 2012). This approach typically yields more compact and interpretable
results than those produced by traditional methods relying on individual genes. The
set-level strategy can also be adopted with similar benefits in predictive classification
tasks accomplished with machine learning algorithms; however, some studies into
the predictive performance of set-level classifiers have yielded rather controversial
results (Abraham et al., 2010; Lee et al., 2008; Mramor et al., 2010; Staiger et al.,
2012).
This thesis addresses the topic of the set-level gene expression data classification
using machine-learning methods and targets the controversy over whether the avail-
able set-level approaches can improve accuracy of machine-learning models. The key
idea behind the set-level techniques consists in exploiting prior knowledge in the form
of predefined gene sets corresponding to various biological processes to enrich the
analysis. Basically, these techniques allow the reduction of data dimensionality by
transforming into an alternative data representation where the data samples are rep-
resented in “activities of the biological processes” instead of the gene activities (gene
expressions). The reduction follows from the fact that the number of the predefined
gene sets is typically much smaller than the number of the measured genes in the
data. At the same time, the set-level methods introduce abstraction that substan-
tially improves results interpretability, mainly because the transformed data samples
are represented by activities of the particular cellular process (in a simplified rep-
resentation using the gene sets) instead of the genes. Furthermore, the abstraction
provides an interesting tool for data integration obtained from different technologies
or even species. We hypothesise that the predictive accuracy of learned models will
increase when the set-level approach is used due to a reduction of overfitting, the abil-
ity to fit random noise instead of the desired phenomenon, caused by reducing the
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number of features1 by the data transformation. For given data and machine learning
methods, predictive model performances depend on a trade off between the number
of features, p, and samples, n, where reduction of the ratio p/n, by decreasing the
nominator or increasing the denominator, can lead to the reduced risk of overfitting.
The main goal of this thesis is to test two hypotheses about the ratio between p
and n which have a severe impact on learned model performance and interpretability,
we address both hypotheses experimentally.
• The first hypothesis is related to the increase of n. We analyze the effect for
various n with constant p not only when data originate from a single homoge-
neous data set but also when the data were integrated from different studies
using transformation to the same abstract representation.
• The second hypothesis is connected to the decrease of p. Two approaches are
used (including their combination): firstly it is the feature transformation from
the “concrete” gene-level into the “abstract” set-level, and secondly we use
traditional machine-learning methods for feature selection.
The contributions related to the first hypothesis are the following. For variable
number of samples, we demonstrate the integration of gene expression data taken
from different platforms and species based on the abstracted data representation. We
learn the classification models on gene set representation corresponding to different
abstraction levels and study whether this abstraction increases classification robust-
ness in cross-species tasks. We also explore different ways of defining gene sets and
empirically test if gene set features outperform the features based on individual genes.
The contributions related to the second hypothesis are the following. Using the
state-of-the-art gene sets, we compare the performance of predictive models based
on the gene-level or the abstracted representation which use both the genuine gene
sets and gene sets assembled without biological relevance, we assess the state-of-the-
art methods for set-level analysis in machine learning settings, and compare various
aggregation methods transforming gene expression data into a new set-level features.
We also assess the performance of novel gene sets based on transcriptional regulatory
network topology.
The final contribution of this thesis is based on an implementation of the used
methodology into online tools xgene.org2 and miXGENE3. The first tool is designed
primarily for the integrated analysis of gene expression data obtained by different
platforms or species. The latter tool, miXGENE, provides a general framework for
analysis of the genetic (gene expression) and epigenetic (DNA methylation) data .
1A general term for a measurable property of an object or phenomenon (e.g, level of gene tran-
scription activity for a given gene).
2http://xgene.org
3http://mixgene.felk.cvut.cz
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1.1 Thesis outline
The rest of this thesis is organized as follows. Chapter 2 provides the background of
this work: (i) we briefly introduce relevant aspects of molecular biology and machine
learning, and (ii) summarize the state-of-the-art methods. In Chapter 3 we state
our working hypotheses. Chapter 4 contains an experimental evaluation of the first
hypothesis, and Chapters 5 and 6 contain an experimental evaluation of the second
hypothesis. Chapter 7 describes the tools, XGENE.ORG and miXGENE. The final
Chapter, 8, summarizes the results of our experiments, concludes the whole work,
and indicates possible ways to extend this thesis.
3
Chapter 2
Background
The aim of this chapter is to describe the biological and machine-learning background
of this thesis. Firstly, we briefly introduce relevant aspects of molecular biology
(Section 2.1). In the next sections, we review basic methods for gene expression
data analysis (Section 2.2) and the state-of-the-art set-level analysis methods (Sec-
tion 2.3). The last three sections are dedicated to the machine-learning viewpoint of
gene expression analysis; Section 2.4 describes the fundamentals of machine learning,
Section 2.5 introduces machine learning for gene expression analysis, and Section 2.6
presents usage of machine learning methods for the set-level analysis.
2.1 Gene expression in the cell
The complete hereditary information of any known living organism is stored in the
cell as a deoxyribonucleic acid (DNA) molecule. The DNA molecule is composed
of a sequence of simpler units, nucleotides, where each nucleotide contains one of
four specific biological compounds1 and can be seen as a sequence of symbols drawn
from a 4-symbol alphabet. Typically, the DNA molecule is composed of two such se-
quences (strands) and organized as a double helix. The sequences are complementary;
a symbol on one strand determines the symbol on the opposite strand. This arrange-
ment allows an effective replication of the information during the gene multiplication
or copying of the information into another information-storing molecule, ribonucleic
acid (RNA), which differs from the DNA (i) by one nucleobase (using uracil instead
of thymine) and (ii) typically remains single-stranded (Fig. 2.1).
The basic elements of the hereditary information are continuous sequences of
DNA, genes. Each gene can either encode an RNA sequence which by itself plays a
role in the cell, or this sequence serves as a template for synthesis of a polypeptide;
an aminoacid sequence, which is done in ribosomes (Fig. 2.1). Long polypeptide
sequences, proteins, are the essential substance of life; they constitute a wide range of
different functionalities: proteins take part in different molecular functions, comprise
cellular components, or participate in biological processes.
1The compounds (nucleobases) are guanine, adenine, thymine, and cytosine.
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Figure 2.1: Flow of genetic information (also known as “the central dogma of molec-
ular biology”). Replication, provided by the DNA polymerase, occurs during the
transmission of hereditary information to the progeny of any cell or organism. Tran-
scription, provided by the RNA polymerase, is a process where information stored in
a sequence of DNA, gene, is transferred into an mRNA sequence. Translation is per-
formed by ribosomes and consists in a protein production on the basis of the mature
mRNA. (From Wikimedia Commons)
Gene expression is a general name for a process during which genes are pro-
cessed into functional gene products, proteins, in the case of protein coding genes,
or RNA sequences, in cases where the non-coding genes (e.g., small RNA sequences,
like tRNA or microRNA, which participate in protein production or gene regulation,
respectively). This process is comprised of two phases: (i) transcription, in this phase
a copy of a particular gene (mRNA) is made according a specific part of the DNA
sequence by a special enzyme, RNA polymerase, and (ii) translation, which consists
of building a protein according to the mRNA sequence in special protein complexes,
ribosomes. Generally, the genetic information in the cell always flows from the DNA
to the RNA to the protein (Fig. 2.1).2
2In special cases (e.g., induced by viruses such as HIV) the flow can be from the RNA to the
DNA or from the RNA to the RNA.
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Gene expression regulation in prokaryotes
Simple prokaryotic organisms (e.g., bacteria) have a relatively simple cellular struc-
ture in comparison to higher organisms. The main difference consists in a missing
membrane separating the place which contains most of the cellular genetic material,
nucleus, from other cellular parts. In the prokaryotic DNA, genes are organized in
operons, clusters with associated regulatory elements and transcribed as a single unit.
Each operon contains one or more DNA regions where the RNA polymerase begins
with the transcription (promoter regions) and a terminator region where the RNA
polymerase releases the DNA and, therefore, finishes the transcription. Transcription
rate is controlled by proteins which act as activators or suppressors of transcription
(transcription factors). These proteins bind near the promoter region (as a response
to external or internal cell stimuli) and positively or negatively affect the transcrip-
tion process. Thanks to the simple architecture of the prokaryotic cell, translation
starts as soon as the mRNA is free, so the translation rate is proportional to the
transcription rate unless it is decreased by some functional proteins (enzymes) which
can affect the translation rate of the ribosomes.
Gene expression regulation in eukaryotes
The eukaryotes typically constitute multi-cell organisms with a complicated cellular
structure where the cell nucleus is clearly separated from the other cellular compart-
ments. Regulation of the gene expression occurs primarily at three distinct levels. (i)
At the transcriptional level—in contrast to prokaryotes—structures like the operons
are missing and an additional regulation is provided by changes in the DNA by mech-
anisms changing spatial structure of the DNA called histone acetylation and DNA
methylation. (ii) Post-transcriptional modifications lead to production of different
mRNA sequences from a single transcribed gene which subsequently lead to the pro-
duction of different proteins. It is either caused by trimming the non-coding regions
of the gene and alternative assignment of the remaining sequences (alternative splic-
ing) or rarely by direct modifications of certain transcript bases (RNA editing). (iii)
At the translational level, the regulatory mechanisms operate with several aspects of
mRNA sequences as a response to changing cellular requirements (e.g., mRNA sta-
bility). It is worth noting that mRNA stability of prokaryotes is only a few minutes,
but in the eukaryotic cell it can stretch from dozens of minutes to a day. There are
also post-translation control mechanisms which ensure persistence of proteins which
can be from minutes to weeks for eukaryotes.
Organization of gene interactions in pathways
From the genomic point of view, genes constitute networks or pathways of com-
plex dynamic interactions providing various cellular functions (e.g., cell signaling
or metabolism) in order to keep a cell in homeostasis, represented as stable molecu-
lar attractor states towards which individual cells are drawn over time (MacArthur
et al., 2009). The interactions are basically indirect; particularly, they are provided by
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gene-encoded mRNAs and proteins and by other substances in the cell (e.g., interme-
diate products of the cellular metabolism). Various databases (e.g, Croft et al., 2014;
Kanehisa et al., 2004) provide such pathways which cover processes like metabolism,
information processing, and diseases (Kanehisa et al., 2004).
Functional annotation of genes and gene products
Controlled vocabularies with gene annotations are typical instances of knowledge of
gene and protein roles in the cell. One of the biggest examples of these vocabularies is
represented by the Gene ontology (GO) project (Ashburner et al., 2000) which provide
three ontologies describing genes and the products, places, or processes where they
affect: (i) cellular component, which refers to places in a cell where a product is
active, (ii) molecular function, that defines the biochemical activity of gene products
and (iii) biological process referring to a biological objective to which a gene product
contributes.
2.2 Gene expression data analysis
The advent of technologies capable of measuring gene expression on an entire genome
level have brought new challenges to the analysis of gene expression data (Zhang,
2006).
2.2.1 High-throughput technologies
High-throughput technologies, like microarrays (Lipshutz et al., 1999) and next-
generation sequencing (Wang et al., 2009), bring a relatively cheap way to analyze the
gene expression. These technologies provide a complete gene expression snapshot of
cells where the number of interrogated genes may vary according the analyzed organ-
ism from a few thousand for bacteria to tens of thousands for higher organisms3. The
area of applicability of these technologies ranges across molecular-level-based disease
diagnostic, drug response analysis, and other areas of molecular biology.
DNA microarrays are a technology measuring the presence of mRNA transcripts
by a binding4 of the transcripts on probes corresponding to interrogated genes (Fig.
2.2). Not in all cases does one probe measure the presence of one mRNA transcript;
for some genes several probes measure the same gene mRNA transcript, and—on
the contrary—some probes can bind mRNAs from two or more genes. Physically,
microarrays are small solid chips with probes attached to their surface. Each probe
occurs in many copies (probe set) in order to increase stability of the results. As the
first step of a microarray experiment, examined sample RNA sequences are labeled
by a florescent tag, then the sequences are hybridized on the chip, washed away, and
scanned. The result is an image with intensities for each spot (probe) where the
3Human genome contains approximately 20,000 protein-coding genes.
4The process of binding, hybridization, establishes sequence specific interaction between a mRNA
transcript and a probe.
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Figure 2.2: Hybridization of target samples and probes in a microarray. The whole
process is the following: (i) the available samples are purified, (ii) labeled by a fluores-
cent label, (iii) then follows the hybridization and washing to remove weakly bound
samples, and (iv) scanning. (From Wikimedia Commons)
strength of the signal from a probe depends upon the quantity of the target sample
(the transcription rate). After normalization (e.g., Bolstad, 2004), the intensities are
ready for analysis.
The next-generation sequencing methods measure the available mRNA transcripts
directly in a quantitative manner; therefore, they are able to determine the RNA
expression rate more accurately than microarrays (Wang et al., 2009).
In the rest of the thesis only single-channel Affymetrix GeneChip microarray data
are considered. This is solely due to their availablity and for simplicity of the exper-
imental pipeline. Performing the same experiments on data obtained by comparable
platforms or the next-generation sequencing should bring similar or even more sig-
nificant result when more accurate methods are used. We note here that we use the
terms “genechip” and “microarray” interchangeably from now on.
2.2.2 Gene level analysis of high-throughput data
Analysis of the high-throughput gene expression data is a challenging task. The main
challenge resides in the size of the processed data, inherent noise, and complicated
interactions among genes. Typically, we face data which contain a relatively huge
number of measured genes and a small number of interrogated samples. The typical
datasets contain measurements of thousands (or even tens of thousands) of genes, g,
while the number of samples, n, does not exceed hundreds and is very often only a
few dozen; thus, the ratio p/n is about 100–1000.
The microarray experiment provides a matrix of gene expressions. Here we assume
that the matrix columns correspond to individual observations and each observation
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is a vector of real values representing expressions of the interrogated genes. In this
thesis, we presume that the samples pertain into one of two sample classes (e.g.,
healthy and diseased samples).
A basic approach for the analysis of the data is to find a list of differentially
expressed genes which exhibit a strong relationship between the gene expression and
the response variable. One can use fold change, statistical tests like the t-test or
its non-parametric equivalents (Wilcoxon’s signed-rank test and rank-sum test). As
results, the methods provide a list of differentially expressed genes and test scores.
The genes with extreme scores (small-enough p-values) are declared as significant.
Unfortunately, an inherent problem of this approach is caused by noise in the data
and the simultaneous statistical inference on the complete set of genes which lead
to incorrectly rejecting the null hypotheses and an overoptimistic conclusion about
achieved significance (the multiple testing problem). Therefore, some methods use
more appropriate methods to assess the significance, namely they implement multiple
testing criterion (FWER) or the false discovery rate (FDR) (Benjamini and Hochberg,
1995) control procedures. (For a detailed overview of these methods see, e.g., Zhang,
2006, Ch. 4).
Another major challenge is to interpret the results obtained from the lists provided
by the above mentioned methods. The challenge consists in difficult interpretability
of the list in a biological context due to its length and the fact that genes can play
a role in many different processes in the cell. Interpretation of such a list can be
easier if genes from a gene list exhibit similarities in their functional or chromosomal
location (Goeman and Bu¨hlmann, 2007). The overrepresentation analysis (ORA)
provides such a tool which allows biological terms significantly covered by the dif-
ferentially expressed genes to be found. The general idea of the ORA is to look for
an abnormal representation of significantly expressed genes in a particular biological
term using, e.g., the χ2 test or the hypergeometric test (Goeman and Bu¨hlmann,
2007). A typical choice for the biological terms are the pathways or the GO terms
represented as sets of genes.
The main limitations of the ORA approach, according to Khatri et al. (2012), are
the following: (i) ORA ignores information about the strength of how the genes are
differentially expressed. (ii) Genes marked as not significant are removed from the
interpretation; which means that informative (but non-significant) genes are removed
from the subsequent analysis. (iii) This approach (e.g., the hypergeometric or the χ2
tests) assumes independence among the genes. (iv) ORA also assumes independence
between the gene sets, which is certainly not true.
The main advantage brought by the set-level analysis is compactness and improved
interpretability of the analysis results due to the smaller number of the set-level
units in comparison with the number of genes. Indeed, the long lists of differentially
expressed genes are replaced by shorter lists of more informative units corresponding
to actual biological processes.
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2.3 Set-level gene expression analysis
More advanced methods can consider insignificant-but-coordinated changes in the
gene sets. Sometimes these methods are called functional class scoring methods (FCS)
(Khatri et al., 2012). The biological utility of this approach was demonstrated by a
study (Mootha et al., 2003) in which a significantly downregulated pathway-based
gene set was discovered in type 2 diabetes data despite no significant expression
change being detected for any individual gene; note that ORA methods cannot detect
any significantly overrepresented gene set in such data.
There are a plethora of FCS methods for the set-level analysis, but all of them
follow a relatively simple structure. According to Ackermann and Strimmer (2009),
the FCS methods use two general alternative approaches only. In the first approach,
the methods compute gene-level statistics (e.g., the t-test), establish a rank transfor-
mation of the gene scores (e.g., p-value), compute statistics for the gene sets using
the computed rank, and assess their significance (e.g., Mootha et al., 2003, by the
Kolmogorov-Smirnov statistics). In the second approach, the methods compute the
set-level statistics and significance directly (e.g., Goeman et al., 2004). Results pro-
vided by FCS methods can vary significantly depending on methods used for rank
transformation, gene set significance assessment, and—most importantly—evaluated
null hypothesis (Ackermann and Strimmer, 2009; Goeman et al., 2004).
2.3.1 Current approaches
Several papers consider a performance comparison of the FCS set-level methods in the
recent years (Dinu et al., 2008; Liu et al., 2007b; Song and Black, 2008; Tarca et al.,
2013). This task is inherently challenging due to the absence of gold standard bench-
mark data to evaluate the methods; therefore, the key idea behind the evaluation in
the mentioned papers is based on an assessment of an expected or known performance
on real or simulated datasets. Particularly, for the real data sets, there are usually
known gene sets associated with the phenotype. Liu et al. (2007b) compare Global
test, ANCOVA Global test, and SAM-GS on simulated data and conclude that all
methods have a similar statistical power. Dinu et al. (2008) evaluate methods on
real data in which differentially expressed gene sets are predictable biologically from
the phenotype. According to their evaluation, SAM-GS, Global test, and ANCOVA
Global test perform better than GSEA (Subramanian et al., 2005), sigPATHWAY
(Tian et al., 2005), and PLAGE (Tomfohr et al., 2005). Song and Black (2008) as-
sess five methods on real and simulated data and conclude that GSEA5, Global test,
and PCOT2 (Song and Black, 2006) perform similarly, but better than SAFE (Barry
et al., 2005), GSEA6, and sigPATHWAY. The most recent paper by Tarca et al.
(2013) compares 16 methods on 42 real microarray data sets with the following best
performing methods: Global test, PLAGE, PADOG (Tarca et al., 2012).
5Improved implementation of GSEA with different significance assessment procedure.
6Standard implementation of GSEA by Subramanian et al. (2005).
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Global test was among the best performing methods in all four papers, and
conversely, GSEA method, despite its wide popularity among biologists, performed
poorly in the all the aforementioned papers which considered this method.
2.3.2 Limitations and alternative approaches
The ORA and FCS methods are primarily limited by considering no dependencies
among used gene sets.7 The methods are also very restricted by how they use the
available knowledge since only associations of biological terms with the gene sets are
exploited during the analysis. However, some other approaches proceed beyond the
simple set-level approach and consider known interactions among genes in pathways
and transcriptional regulatory networks (e.g., Alexeyenko et al., 2012; Geistlinger
et al., 2011; Rahnenfu¨hrer et al., 2004; Tarca et al., 2009).
Obviously, the set-level methods give absolutely the same results when a change
in topology description occurs, in comparison to net-level methods (which consider
the interactions). The set-level methods ignore the differing importance of genes
emerging from their place in pathways (placed downstream or upstream in signal
transducting cascades). Including but not limited to the following issues, Khatri
et al. (2012) point out a low resolution of knowledge bases, their fragmentation,
incomplete and inaccurate annotations, missing condition and cell specific information
(i.e., experiment conditions, cell type), and the fact that no “existing approach can
collectively model and analyze the high-throughput data as a single dynamic system.”
Other issues arise from the limited quality of the available data. All these deficiencies
lead to a limited use of the available information about the gene interactions and
make an effective analysis challenging.
2.4 Machine learning fundamentals
Machine learning deals with artificial systems learning from given data in an au-
tonomous manner. Regarding the available mass of gene expression data with their
amount and extent ranging beyond the capacity of any living organism, machine learn-
ing proposes an interesting alternative for data analysis and knowledge discovery. In
this thesis, we focus on a subset of the machine learning framework—supervised ma-
chine learning. From the molecular biology viewpoint, it provides a form of data
analysis going beyond the mere identification of differentially expressed genes or gene
sets; particularly, it provides tools designed to solve the problem of inferring a function
from data samples and their labels automatically.
Given input and output random variables X and Y , respectively, the task is
defined as fitting a model, Y = f(X)+ε, where Y denotes quantitative or qualitative
output, for regression or classification problems, respectively, X is a p-dimensional
vector (feature vector) of components Xj (features), and ε represents noise in the
data (this term is typically not used for qualitative output).8 The goal of supervised
7There are a few exceptions (e.g., Goeman and Mansmann, 2008; Tarca et al., 2012).
8Definition of the supervised learning problem in this section follows Hastie et al. (2001).
11
learning is to find a useful approximation of the model function, fˆ , by learning from
examples. For given n observations of an analyzed system (e.g, gene expression data
from healthy and diseased patients), we extract inputs and outputs of the observations
and assemble a training data set T = {(xi ∈ X, yi ∈ Y )|i = 1, . . . , n}, and feed a
learning algorithm.
The learning process can be seen as a search or optimization problem. Let us
assume that there is an unknown joint probability distribution Pr(X, Y ) from which
the training examples were drawn, the criterion for choosing f is expected prediction
error (EPE),
EPE(f) = E (L(Y, f(X)) ,
where L(Y, f(X)) defines a loss function for penalizing errors. In what follows we
assume that the output variable Y is qualitative, the loose L(y, y′) = 1 whenever y 6=
y′ and zero elsewhere, and we call function f a classifier and its EPE a classification
error. The EPE usually cannot be computed directly, since Pr(X, Y ) is typically not
known, but it can be estimated empirically on a given data set S as
EPES(f) =
1
|S|
∑
(x,y)∈S
L(y, f(x)).
The complexity of the classifier (i.e., degree if f is a polynomial function) de-
termines its classification error on used training data set (training error) and also
impacts its generalization (classification error on data used for the evaluation that is
testing error). An ideal classifier provides low error on training and testing data sets.
If the classifier is too complex (flexible enough to fit the all training data very well),
then the training error is close to zero, but its performance on testing data is poor
(e.g., fits noise). If the classifier is too simple, then both training and testing error
are too large. This complexity issue is called the bias-variance trade-off; because, one
seeks simultaneously to minimize error over different training data sets (bias) and
sensitivity of the classifier to small changes in the training data set (variance). Two
extreme types of classifier misbehavior can occur in given data. The first one (under-
fitting) occurs when the model is not able to fit the data due to its low complexity.
The second one (overfitting) is caused when the fitted model is too complex and it is
not able to generalize beyond the training data.
Other factors can also affect overfitting (and underfitting) of the classifier, two of
them are particularly important to the gene expression data: (i) Each classifier needs
an adequate number of training samples for its learning phase; in the case of their
insufficient number, the learning process can lead to overfitting. Therefore, a high
complex “true” function f can be learned only when enough of the training samples
are available. (ii) High dimensional input space of X (possible with many irrelevant
features) can confuse the learning algorithm and lead to a higher variance of the
predicted error which implies the overfitting. In practice, a method for the feature
reduction of the input space can be used.
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2.5 Machine learning for gene expression analysis
Machine learning techniques have been explored since very early studies on microar-
ray data analysis (Eisen et al., 1998; Golub et al., 1999). Especially successful were
supervised methods (for class prediction or regression) and unsupervised algorithms
(for clustering). Gene expression data combined with machine learning methods revo-
lutionized cancer classification which had been based solely on morphological appear-
ance. An important milestone was a successful demonstration of cancer classification
based solely on high-throughput gene expression data (Golub et al., 1999). Golub
et al. (1999) used class discovery and class prediction techniques on acute myeloid
leukemia and acute lymphoblastic leukemia microarray data in order to distinguish
between the two cancer types using the data without any additional knowledge and
to derive a class predictor able to determine the leukemia class for a new unseen
case, respectively. While the clustering on samples in the above mentioned case was
used, the clustering on gene level also provides an important insight in analyzed
gene expression data; these algorithms have manifested the ability to find groups of
co-expressed genes with similar functions which makes the clustering algorithms sim-
ple but useful tools for gaining leads to gene functions with missing or unavailable
functional description (Eisen et al., 1998).
There is no one-size-fits-all supervised approach. Some methods are particularly
suitable for high dimensional problems when p n (Hastie et al., 2001, Ch. 18) where
an appropriate algorithm can quickly provide good models despite the low number of
samples, abundance of correlated features, and biological or technical noise in data
providing platforms (e.g., gene expression microarrays). Other methods can still be
considered due to their properties, e.g, a natural way to include biological knowledge
which not only improves classifiers interpretability but also can positively affect the
bias-variance tradeoff. Generally, forms of the learned classifiers can range from (fast
learning and less interpretable) geometrically conceived models such as Support Vector
Machines (Cortes and Vapnik, 1995), which have been especially popular in the gene
expression domain, to (slower learning and easily interpretable) symbolic models such
as logical rules or decision trees that have also been applied in this area (Gamberger
et al., 2004; Huang et al., 2010; Zintzaras and Kowald, 2010).
A wide range of different approaches implementing various learning models have
been proposed for analysis; therefore, Allison et al. (2006) point out that the need
for thoroughly evaluating existing techniques currently seems to outweigh the need to
develop new techniques. The main reason is the absence of a gold standard evaluation
technique, which is nearly impossible to resolve, so either simulated or real data with
known results are used for evaluation (refer to the evaluation of the state-of-the-art
gene-set-based analysis methods in Section 2.3.1). Such solutions are unfortunately
difficult and prone to overoptimistic findings (Ioannidis, 2005; Jelizarow et al., 2010).
An advantage of the supervised machine learning approach, in comparison to the
set-level enrichment methods in Section 2.3.1, consists in a natural way to estimate
the performance of learned models which can be implemented, e.g., by the k-fold
cross-validation (Hastie et al., 2001, Ch. 7). The only drawback of this approach is
the need for a reasonable number of data samples.
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Other machine learning approaches have also been used, including association
rules mining (a method formerly invented for business transaction data), time series
analysis methods, and semi-supervised clustering (Zhang, 2006).
2.6 Machine learning with the set-level approach
The combination of set-level techniques with predictive classification has been sug-
gested (Chen et al., 2008; Liu et al., 2007b; Tomfohr et al., 2005) or applied in specific
ways (Bild et al., 2006; Guo et al., 2005; Holec et al., 2009b; Lee et al., 2008; Wong
et al., 2008) in the previous studies; however, a focused exploration of the strategy
has commenced only recently (Abraham et al., 2010; Hwang, 2012; Mramor et al.,
2010; Staiger et al., 2012, 2013).
The set-level framework is adopted in predictive classification as follows. Sample
features originally bearing (normalized) expressions of individual genes are replaced
by features corresponding to gene sets. Each novel feature aggregates the expressions
of genes contained in the corresponding gene set into a single real value; in the
simplest case, it may be the average expression of the contained genes. The expression
samples are then presented to the learning algorithm in terms of these derived set-
level features. Informally, classifiers learned using the set-level features acquire forms
such as “predict cancer if pathway P1 is active and pathway P2 is not” (where activity
refers to an activity score computed from expressions of pathway member genes). In
contrast, classifiers learned in the standard (gene-level) settings derive predictions
from expressions of individual genes where it is usually difficult to find relationships
among the genes involved in such models and to interpret them in terms of biological
processes. Further motivation for extending the set-level framework to the machine
learning (besides the increased interpretability already mentioned) is the possibility to
compare learned models straightforwardly on predictive performance (Demsˇar, 2006).
In contrast to the machine learning approach, it is not clear if significant results found
by the ORA and FCS methods imply good predictive performance (Abraham et al.,
2010).
The main issue of the set-level transformation through aggregation is that the
lifting features to the set-level incurs a significant compression of the training data
since the number of considered gene sets is typically much smaller than the number of
interrogated genes. On the other hand, reducing the number of sample features may
mitigate the risk of overfitting and thus, conversely, contribute to higher accuracy.
In machine learning terms, introduced in Section 2.4, reformulation of data samples
through set-level features increases the bias and decreases the variance of the learning
process (Hastie et al., 2001). Another aspect of transforming features to the set-level
is that the prior biological knowledge is channeled into learning through the prior
definitions of biologically plausible gene sets.
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Method References
Mean (median) Azuaje et al. (2010); Guo et al. (2005); Liu et al. (2007a);
Abraham et al. (2010)
U-statistics Abraham et al. (2010)
SPCA Chen et al. (2008),
PCA Bild et al. (2006); Levine et al. (2006); Liu et al. (2007a);
Tomfohr et al. (2005)
CORG Lee et al. (2008)
PLS Liu et al. (2007a)
ASSESS Edelman et al. (2006)
SetSig Mramor et al. (2010)
Other methods Breslin et al. (2005); Chuang et al. (2007); Efroni et al. (2007);
Rapaport et al. (2007); Taylor et al. (2009)
Table 2.1: Overview of set-level methods applicable in the machine learning settings.
2.6.1 Methods overview
Methods applicable for the gene set activity score computing (set-level aggregation)
are summarized in Table 2.1. All of them transform input data into space of new
set-level features. Generally, these methods use similar or exactly the same aggrega-
tion mechanism, like the FCS methods in Section 2.3.1(e.g., 1st component from the
PCA can be used in both approaches). Consequently, these methods share similar
problems; they do not consider dependencies among gene sets and interactions among
genes.
Some work (Breslin et al., 2005; Chuang et al., 2007; Efroni et al., 2007; Rapaport
et al., 2007; Taylor et al., 2009) suggests methods which exploit topology information
of the pathways in order to estimate the activity level, but we recall here that these
(net-level) methods are not considered in this work.
Several papers have analyzed properties of the set-level approach in machine learn-
ing settings in recent years (Abraham et al., 2010; Hwang, 2012; Mramor et al., 2010;
Staiger et al., 2012, 2013). All the papers (except Hwang, 2012) deal with cancer data
and agree on the conclusion that the gene set approach, generally, do not improve the
predictive accuracy in comparison to the gene-level-based alternative, but provides
rather competitive results. Short descriptions and references to the available meth-
ods are in Table 2.1. These studies perform the evaluation mainly on pathways and
GO terms (see Section 2.1) obtained from Molecular Signatures Database (MSigDB)
(Subramanian et al., 2005) which contains collections of commonly used gene sets for
the set-level analysis. MSigDB contains the following gene set collections: positional
gene sets defined by genes from the same genomic location (C1), curated gene sets,
e.g., KEGG pathways (Kanehisa et al., 2004) (C2) , motif gene sets which represent
conserved regulatory elements (C3), computational gene sets which were mined from
cancer related data (C4), and GO gene sets corresponding to the GO terms.
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Abraham et al. (2010) analyze the predictive performance and stability of several
set-level aggregation methods on a set of five cancer-related datasets using different
gene set collections (MSigDB gene sets C1, C2, C3, C4, and C5). They evaluate
three general approaches. (i) An approach where gene expressions of each sample are
transformed into one value by simple statistics (mean, median, medoid9, and a modi-
fication of the mean approach based on the t-statistics). (ii) In the second approach,
the first principal component (PC) obtained by the PCA represents the aggregated
gene expressions for a give gene set. (iii) The last approach is based on a mean rank
comparison of genes inside and outside a gene set, this approach computes activity
scores using Wilcoxon’s rank sum statistics (U-statistics). For classification, they use
the centroid classifier with a feature selection strategy based on the highest absolute
centroid weight, and validate the results inside each dataset (internal validation) and
between each of the other datasets (external validation). The main findings of this
experiment are: (i) almost the same predictive accuracy of the set-level approaches as
a baseline experiment; particularly, some of the aggregation methods (mean, median,
medoid, and set t-statistic) showed similar performance to the baseline based on in-
dividual genes, but the first PC and the U-statistic showed statistically significant
performance reductions, (ii) more consistent rankings of features within each dataset,
and (iii) more stable classifiers across different datasets.
The paper by Mramor et al. (2010) provides a large comparison of set-level meth-
ods on 30 cancer datasets using gene sets based on the MSigDB gene sets (C2 and a
joint collection of C1 and C5). In comparison with the previous paper, they do the
internal validation only, implement no feature selection, and compare the algorithms
in a correct unbiased way. For models learning, they use support vector machines,
logistic regression, and k-nearest neighbors. Mramor et al. (2010) compare six aggre-
gation methods (SetSig, CORGs, mean, PCA, median, and Assess) with a baseline
approach without the set-level aggregation, and use Friedman’s non-parametric statis-
tics for models performance comparison, an approach proposed by Demsˇar (2006).
Mramor et al. (2010) conclude that their method, SetSig, performs better than the
other method, but worse than the gene-level-based (baseline) approach.
Hwang (2012) analyzes six set-level methods on seven pairs of datasets (each
pair of datasets share the same phenotype for performing the external validation) on
the KEGG pathways. His experiment compares the following aggregation methods:
mean, CORG, ASSESS, PCA, PLS, mean of top 50% of genes10. For classification, the
author uses SVM with the radial basis function as the kernel for the model learning,
and a ranking based on the t-test for the feature selection step. The main paper
result is a ranking of the aggregation methods. The best performing approaches are
ASSESS and mean top 50%, and on the other side, the worst performing method is
mean (mainly for the external validation).
The papers by Staiger et al. (2012, 2013) provide another evaluation of the set-
and net level approaches on C2 gene set collection from MSigDB. In the first paper
9A representant gene with minimal Euclidean distance to the mean is selected for each sample
in this implementation.
10A modification of the mean approach where 50% of genes with the highest ranking, according
the t-test in each gene set, are used.
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(Staiger et al., 2012), the authors perform an evaluation on six breast cancer datasets
and aggregation methods by Chuang et al. (2007) and Taylor et al. (2009) for the
net-based and CORG for the set-based knowledge. Similar to the previous studies,
the authors use the t-test based feature selection and the nearest mean classifier,
logistic regression, and 3-nearest neighbors for the machine learning modeling. In
addition to the above mentioned papers, the authors inspect a case when the gene set
knowledge is randomized. The authors also come to the conclusion that (i) the set-
level methods do not outperform the gene-level approach, (ii) the randomization does
not result in a performance decrease, and (ii)—contrary to the paper by Abraham
et al. (2010)—the stability of the gene-level-based and set-level-based classifiers is
similar when a proper correction is performed. The second paper (Staiger et al.,
2013) provides a comprehensive framework for the set-level approaches evaluation
based on the experimental workflow defined in Staiger et al. (2012), and differs from
its predecessor by using a new single large integrated dataset composed of 12 studies
(containing data from 1600 patients), and implements the other three network-based
methods.
Despite several papers asserting the ability to gain predictive performance by
switching to the set-level (see, e.g, discussion in Mramor et al., 2010), the above
mentioned studies performed on a large collection of data sets clearly show that
none of the mentioned aggregation methods combined the with machine learning can
outperform the baseline approach which does not include the set-level aggregation
and learn models on the single-gene-based data representation.
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Chapter 3
Main hypotheses to test
In this chapter, we define the two central hypotheses of this thesis; we denote them
Hypothesis 1 and Hypothesis 2 (or shortly H1 and H2, respectively). Both of them
are concerned with performance evaluation of the combination of the gene set activity
score methods and the machine learning algorithms with dependence on a changing
number of features, p, and samples, n, used during the learning phase.
The number of available samples affect the optimal choice of a machine learning
algorithm where an insufficient number of the training examples can lead to overfit-
ting (Section 2.4). Unfortunately, due to the nature of gene expression data and the
demanding nature of biological experiments, where a limited number of samples is
very often available only, the risk of overfitting is high; therefore, simple (e.g., lin-
ear or highly regularized) machine learning models are recommended (Hastie et al.,
2001). In relation to overfitting, it is an interesting fact that several studies on breast
cancer diagnosis provided different sets of signature genes with little or no overlap
among them mainly due to a large number of genes slightly correlated with the data
phenotype and a strong fluctuation of the correlation of genes when gene expression
data were measured on a different subset of patients (Ein-Dor et al., 2005).
The gene set activity score methods implicitly introduce two key data aspects
which directly affect the risk of overfitting. The first aspect is switching to more
abstract set-level features reflecting, i.e., complex processes or activity genes residing
near each other on a chromosome. The second aspect is reduction of the number
of features which in the set-level representation is typically much smaller than the
number of genes or probesets.
Here we describe both hypotheses in an abstract way, a more rigorous definition
is available in the respective chapters concerning the evaluation of the hypotheses.
3.1 H1—heterogeneous data integration through
abstraction
Physicians and scientists analyzing the gene expression data deal with the low number
of samples mainly due to the high cost of gene expression profiling, a low number of
available tissue samples in some cases (e.g., when only a limited number of patients
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are in the study), and demanding experimental pipelines. On the other hand, public
repositories often provide data originating from different labs, platforms, or even
species related to the phenotype of interest and, therefore, give us an opportunity to
perform a meta-analysis integrating different studies.
Here we consider the case when additional observations are introduced into an
experiment; particularly, when data from different species are integrated. The obser-
vations from different platforms or species vary in the type of measured features, we
recall that different platforms use different probesets. The abstraction, introduced by
the set-level aggregation, provides a means how to unify observations originated from
different studies by switching from organism or platform specific features to a com-
mon (organism or platform independent) representation. In cases where data come
from different studies on the same organism, the more abstract (“unifying”) features
correspond at least to genes. For cross-species analysis, the generalization can be
acquired by switching to features representing evolutionary conserved structures and
functions (evolutionary conserved genes or gene sets representing the same biologi-
cal function); therefore, the new features are activities of pathways or gene sets, for
example.
We hypothesize that adding the related samples can help to increase predictive
performance. The most important question is whether the combination of the gene
set aggregation and machine learning techniques have a such ability to integrate data
from multiple species with a positive effect on predictive performance. The other
positive effect undoubtedly consists in (i) a possibility to mitigate overfitting due to an
increased number of samples (see Section 2.4), (ii) reduction of coincidental feature-
to-phenotype correlations because of mixing different subsets of patients measured
by different labs, and (iii) potential ability to generalize knowledge beyond a single
species. On the other hand, a combination of irrelevant or seemingly relevant samples
can make it impossible to learn a desired meta-model and even relevant, but biased
(e.g., not properly normalized) samples can also compromise the meta-analysis. We
evaluate this hypothesis in Chapter 4.
3.2 H2—performance of models learned from the
abstracted data representation
The second hypothesis is connected to the decrease of the data dimensionality by
reducing the number of features, p, caused primarily by the data transformation to
the abstracted set-level representation, but also by selection of the most informative
set-level features.
The decrease is important from both the machine learning and biological view-
points. For machine learning modeling, the reduction of feature space can lower the
risk of overfitting by removing irrelevant features which can confuse learning algo-
rithms and lead to higher variance of the testing error. The biological significance
consists mainly in the improved model interpretability since (i) irrelevant features are
likely to be removed (features which do not participate in the final model showing
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a better or equivalent performance) and (ii) the aggregated features are more com-
prehensible, in comparison with single genes, by their direct association to known
biological processes and structures.
We hypothesize that a proper feature selection technique combined with the set-
level transformation could possibly boost the predictive performance in comparison
with the alternative gene-level representation. Furthermore, this combined approach
provides the proper means for the enriched analysis of gene expression data with prior
knowledge. We test this hypothesis in Chapter 5, where hypothesis H2 is evaluated
for the state-of-the-art gene sets, and Chapter 6, where hypothesis H2 is evaluated for
novel experimental gene sets based on transcriptional regulatory networks of prokary-
otic bacteria Escherichia coli.
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Chapter 4
Cross-species and cross-platform
analysis
(Evaluation of Hypothesis 1)
This chapter is dedicated to the evaluation of Hypothesis 1 and is organized as fol-
lows. Section 4.1 introduces cross-species and cross-platform analysis. In Section 4.2
we describe methodological ingredients of our approach consisting of data normaliza-
tion, data integration, predictive classification, and statistical evaluation. Section 4.3
describes and discusses obtained results, and Section 4.4 gives a conclusion of this
chapter.
4.1 Background
The recent exponential growth in publicly available microarray data sets aroused
interest in the meta-analysis of gene expression data originated from different labs,
platforms, or even species.1 At the same time, there is an obvious room for boost-
ing the analysis of actual samples under study with related samples from a public
repository. However, despite the large number of samples, the prohibitive number of
experimental conditions and platforms complicates the construction of a representa-
tive set of samples measured on the same array and there is the need to allow for
heterogeneous platforms to keep the same conditions as in the study of interest. We
examine here the hypothesis (Section 3.1) if the integration based on the set-level ag-
gregation combined with machine learning can have a positive effect on performance
of the learned machine learning models.
Latest cross-platform methods tackle the problems of matching probes on differ-
ent microarray platforms (Kuhn et al., 2008) or their proper normalization (Shabalin
et al., 2008). There are also dedicated tools facilitating cross-platform analysis of gene
expression data (Kim et al., 2011; Lacson et al., 2010). An overview of cross-species
1The Gene Expression Omnibus (GEO) (Barrett et al., 2013) is one of the largest public reposi-
tories for gene expression data. Currently it stores more than 700,000 expression samples and this
number is quickly growing.
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analysis of microarray data is given in Lu et al. (2009). This paper distinguishes
three strategies for combining microarray data sets from multiple species. The first
one is the most straightforward, it takes the same array for all species, the consequent
analysis in principle does not differ from the single species oriented. Obviously, this
approach is suitable for closely related organisms only. The second strategy takes
dedicated platforms for different species, analyzes them independently, and the re-
sults combines in a post-processing phase. In a typical scenario, lists of differentially
expressed genes are found in the individual platforms, later they are compared for
overlap. The third strategy analyzes the microarray data from heterogeneous plat-
forms concurrently. This groups of methods is most relevant to the topic of this
chapter which studies how classifiers learned from single-platform data compare in
terms of predictive accuracy to those learned from data integrated from heteroge-
neous platforms. However these methods have primarily been applied to study the
cell cycle. The individual exceptions report contradictory conclusions. The first re-
search paper (Warnat et al., 2005) that focused directly on cross-platform analysis of
cancer microarray data showed that it improves gene expression based classification
of cancer. On the contrary, Bevilacqua et al. (2012) concludes that a better way
to improve accurate signature from microarray data sets is to apply a meta-analysis
rather than merging all raw data.
Another aspect addressed here is the set-level analysis of gene expression data,
as opposed to the more traditional gene-level analysis approaches. Following the
approach based on combination of machine learning and the set-level aggregation
described in Section 2.6, we firstly group genes into prior determined gene sets based
on relevant prior knowledge. For example, such set may correspond to a group of
proteins acting as enzymes in a biochemical pathway or be a set of genes sharing a
GO term. Naturally, gene sets considered for the analysis may on one hand overlap
while on the other hand their union may not exhaust all the genes screened in the
expression data. Any gene set may then be assigned descriptive values (such as
aggregated expression score, fold change, significance) by aggregation of the analogical
values pertaining to its members. Gene sets thus may act as derived sample features
replacing the original gene expressions.
In the context of cross-platform and cross-species methods, there were also some
efforts to apply gene sets instead of orthologous genes2 (Kumar et al., 2005; Liu et al.,
2007b; Manoli et al., 2006). GO terms or pathways were used as set-level features and
set-level approaches such as GSEA were used for their selection. However, different
platforms and species were analyzed independently and the results were combined in
a post-processing phase as in the aforementioned second strategy.
The main contribution of experiments in this chapter is showing that the gene-
set-based approach naturally enables to analyze in an integrated manner gene ex-
pression data collected from heterogeneous platforms, which may even encompass
different organism species. The practical significance of the current contribution is
at least twofold. First, microarray experiments are costly, often resulting in num-
2DNA sequences of different species are said to be orthologous if they are considered to be
descended from a single sequence of their last common ancestor organism.
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bers of samples insufficient for reliable modeling. The possibility of systematically
integrating the experimenter’s data with numerous public expression samples coming
from heterogeneous platforms, would obviously help the experimenter. Second, such
integrated analysis provides the principal means to discover biological markers shared
by different-genome species.
We consider three types of gene set collections. The first type groups genes that
share a common GO term. The second type groups genes acting in biological path-
ways formalized by the KEGG database. The third type represents a further novel
contribution of our work and is based on the notion of a fully coupled flux, which is
a pattern prescribing pathway partitions hypothesized by Notebaart et al. (2008) to
involve strongly co-expressed genes. These synergize in single gradually amplified bio-
logical functions such as enzymatic catalysis or translocation among different cellular
compartments.
4.2 Materials and methods
The input of our experimental workflow is a set of gene expression samples possibly
measured by different microarray platforms. To each sample are assigned two labels.
The first identifies the microarray platform from which the sample originates, the
second identifies a sample class (e.g., tissue type). The output is a classification model,
that is, a model that estimates the sample class given an expression sample and its
platform label. The model is obviously applicable to any sample not present in the
input (“training”) data, as long as its platform label is also known. The remarkable
property of the output model in our approach is that it is not a combination of
separate models each pertaining to a single platform. Rather, it is a single classifier
trained from the entire heterogeneous sample set and represented in terms of activity
scores (Section 2.6) of units that apply to all platforms, albeit the computation of
these activity scores may be different across platforms. More specifically, the activity
score of a gene set (such as a pathway) is calculated using a different gene set in each
platform. We now describe the individual steps of the method in more detail.
Normalization
The overview and comparison of cross-platform normalization methods for gene ex-
pression data has recently been published by Rudy and Valafar (2011). For exper-
iments presented in this chapter, we applied quantile normalization (Bolstad et al.,
2003) adapted to cross-platform utilization in a similar way as described by Lacson
et al. (2010). Quantile normalization cannot be applied directly as different plat-
forms represent the individual ortholog genes with probesets of various sizes. To
enable quantile normalization, interpolation and aggregation is needed prior to cal-
culating sample quantiles. As a result, all samples independently of the platform
exhibit the same distribution of expression values. We conduct these steps using the
Bioconductor (Gentleman et al., 2004) software.
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Probeset matching
In order to match probes on different microarray platforms we use annotationTools,
a Bioconductor package (Kuhn et al., 2008). The package provides orthology tables
which contain definitions of orthologous genes and allow reliable integration of het-
erogeneous data with satisfactory coverage.
Set construction
During evaluation of H1 we consider three types of prior knowledge. The first type
groups genes that share a common GO term. The second type groups genes acting in
biological pathways formalized by the KEGG (Kanehisa et al., 2004) database. The
third gene set collection type is based on the notion of a fully coupled flux (FCF),
motivated as follows. Many notable biological conditions are characterized by the
activation of only certain parts of pathways (for example, see references Shaw and
Filbert, 2009; Sun and Chen, 2008; Weichhart and Sa¨emann, 2008). The notion of
pathway score implied by the previous gene set may thus often violate intuition and
hinder interpretation. Therefore we extracted all pathway partitions which comply
with the graph-theoretic notion of FCF (Notebaart et al., 2008). It is known that the
genes coupled by their enzymatic fluxes not only show similar expression patterns,
but also share transcriptional regulators, and frequently reside in the same operon in
prokaryotes or similar eukaryotic multi-gene units such as the hematopoietic globin
gene cluster (Notebaart et al., 2008). FCF is a special kind of network flux that
corresponds to a pathway partition in which non-zero flux for one reaction implies a
non-zero flux for the other reactions and vice versa. It is the strongest qualitative
connectivity that can be identified in a network. The notion of an FCF is explained
through an example in Fig. 4.1 (for a detailed definition, see reference Notebaart et al.,
2008). Pathway partitions forming FCF’s constitute the third gene set collection.
Each type of prior knowledge is represented as a gene set collection where, e.g.,
each pathway is represented as a gene set without considering any type of additional
interactions. Since each above mentioned gene set represents a biological property
shared among different organisms, a gene set collection can be represented by genes
specific for a certain organism using the orthologous genes definitions as a kind of
dictionary.
In what follows, gene sets act as features acquiring a real value for each sample.
Formally, let G(k) be the set of genes interrogated by given platform k ∈ K and Σ is
a gene set collection of a particular type. We define a mapping:
AG(k) : R|G
(k)| × Σ→ R.
For any expression sample s(k) = (e1, . . . , e|G(k)|) ∈ R|G(k)| obtained from platform k,
the mapping AG(k)(s
(k),Γ) should collectively quantify the activity score of genes in
set Γ ∈ Σ in a biological situation (e.g., a tissue type) sampled by s(k). Typically, not
all members of Γ will be measured by platform k and the computation of AG(k)(s
(k),Γ)
will be based on expressions of the genes in Γ∩G(k). For experiments in this chapter
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Figure 4.1: Fully coupled fluxes in a simplified network with nodes representing chemi-
cal compounds and arrows as symbols for chemical reactions among them. Each arrow
can be labeled by a protein. R3, R4 and R5 are fully coupled as a flux in any of these
reactions implies a flux in the rest of them. Note that R1 and R3 do not constitute
a FCF as a flux in R3 does not imply a flux in R1.
we define AG(k)(s
(k),Γ) as the average of expressions measured in s for all genes in
Γ∩G(k). Although there are more sophisticated methods to instantiate AG(k)(s(k),Γ)
(see Section 2.6), we use the average mainly due to the fact that this method—unlike
the other more sophisticated methods—computes set-level activities independently
to other samples. We consider this approach as sufficient and appropriate mainly
because (i) the difference between aggregation by average and the best performing
method is not significant on comparable gene sets (Mramor et al., 2010), (ii) the
evaluation of H1 requires learning on datasets with relative small number of samples,
and (iii) most importantly application of this aggregation approach is straightforward
in comparison to other methods which were designed for single-platform data only.
However, we admit the re-implementation of the other set-level aggregation methods
in cross-platform and cross-species manner could bring more significant results.
Our reasoning above assumes the aggregation of gene expression measurements.
Precisely speaking, genes themselves aggregate one or more measurements since mul-
tiple probesets can represent the same gene. Here, the expression of a gene is simply
defined as the average of the corresponding normalized probeset measurements, de-
spite certain caveats of this approach.3
Set-level data integration
The goal of this methodological step is to integrate heterogeneous expression samples
into a single-tabular representation (the integrated representation contains samples
sharing a common feature set defined by a gene set collection, e.g., a set of path-
ways) that predictive classification algorithms can process. Formally, we have a set
of expression samples from all the platforms S = {s(k)1 , s(k)2 , . . . , s(k)n } where k ∈ K,
3For example, Affymetrix chips contain probesets representing the same gene that cannot be
consolidated into unique measures of transcription due to alternative splicing, use of alternative
poly(A) signals, or incorrect annotations (Stalteri and Harrison, 2007).
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Figure 4.2: Integrating expression data collected from heterogeneous platforms into
a unified tabular representation of set-level aggregation statistics. If these platforms
pertain to different organisms, we assume that (an ortholog of) each gene set, Γi,
(e.g., cellular pathway) exists in each of the organisms.
s
(k)
i ∈ R|G(k)|, and n is number of all the measured samples we intend to integrate. We
wish to obtain a new representation S¯ = {s¯(k)1 , s¯(k)2 , . . . , s¯(k)n } where each s¯(k)i ∈ R|Σ|.
This aim is achieved using the above mentioned gene set aggregation concept.
Formally, using gene set collection Σ = {Γ1,Γ2, . . . ,Γm}, for each sample s(k)i we
stipulate:
s¯
(k)
i =
(
AG(k)(s
(k)
i ,Γ1), . . . , AG(k)(s
(k)
i ,Γm)
)
.
Naturally, sample s¯
(k)
i then inherits the class label from s
(k)
i . The integration principle
is exemplified in Fig. 4.2. The most straightforward representation based on the
ortholog genes is used as the baseline representation to evaluate the effect of set-level
features.
Classification and Validation
The final step of the workflow is to employ machine learning algorithms to induce
predictive classification models of the integrated samples. As the achieved unified rep-
resentation S¯ can be processed by virtually any machine learning algorithm. Since
support vector machine learners are known to cope well with the frequent characteris-
tics of gene expression datasets such as noise and strong disproportion in the amount
of genes and samples, we decided to work with them when classification accuracy is the
main concern. When direct human or semi-automated inspection or interpretation of
the target classifiers is needed we decided to take advantage of decision-tree classifiers.
Specifically, we experimented with the SMO support vector machines learner and J48
decision tree learner included the machine learning environment Weka (Witten and
Eibe, 2005).
The design of the experiments and the validation protocol for Hypothesis 1 is
dictated by the following questions we wish to address empirically.
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Q1 How do classifiers learned from single-platform data compare to those learned
from data integrated from heterogeneous platforms in terms of predictive accu-
racy?
Q2 How do classifiers based on original single gene expressions compare in terms of
predictive accuracy to those based on activity of biologically meaningful gene
set collections?
Q3 Do classifiers based on gene set collections improve those based on single genes
namely in situations when combining cross-species expression data characterized
by only rough similarity in phenotype markers?
Note that while Q1 is evaluated on orthologous genes where we compare the mod-
els learned on the integrated and single-platform data, the assessment of Q2 is consist-
ing of the learned model performance evaluation on integrated datasets with different
levels of generality; particularly, we compare the aggregated and non-aggregated data
(with gene sets and orthologous genes as features, respectively) . In the case of Q3,
we are concerned with “difficult domains” only which have the following character-
istics: (i) the individual single-platform gene-based models poorly generalize to the
samples taken from the alternative platform (e.g., the Mus musculus platform if the
original was a Homo sapiens platform), (ii) the general cross-platform model is large
in its size (a classification tree with a large number of nodes) in comparison with the
single-platform models derived for the same domain. The initial assumption is that
gene sets shall increase the robustness of classifiers and help to increase their gener-
ality when applied across platforms; therefore, we compare model sizes of classifiers
learned on integrated and single-platform data.
We are interested in the insights Q1-Q3 for both the “data-rich” and “data-poor”
situation (for both small and large sets of expression samples). Therefore the pre-
ferred means of assessment is through learning curves which are diagrams plotting an
unbiased estimate of the classifier’s predictive accuracy against the proportion p of
the available data set used for its training. The accuracy estimate for each measured
p was obtained by inducing a classifier 100 times with a randomly chosen subset (of
proportional size p) of the entire data set and its accuracy is tested on the remaining
data not used for training. In each such step, the 100 empirical accuracy results
were averaged into the reported value. We let p range from 0.1 to 0.5 to prevent
statistical artifacts arising from overly small sets used for training or testing and
avoid single-platform tasks with large sample sets that do not ask for cross-platform
generalization.
Statistical evaluation
All statistical tests conducted are based on the Wilcoxon signed-rank test (two-sided
unless stated otherwise). For pairing, we always relate two experiments equal in
terms of all settings except for the one under study. For example, when testing Q1
we gradually fix the way of feature extraction, the domain, the proportion of data
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taken for training, the learning algorithm, but alter the single-platform and cross-
platform way of learning. In this way, a pair of classification accuracies is derived
for every setting. In order to avoid dependency among differential accuracies, median
differential accuracy is calculated for every domain. Having 20 domains, the Wilcoxon
test is applied to the vector of 20 differential accuracies. The hypotheses are tested
at a level of significance of α = 0.05, Bonferroni correction is used to counteract the
problem of multiple comparisons. The stronger t-test is more usual in analysis of
predictive accuracy samples in literature but our preliminary normality tests do not
justify its application. Given the extent of the collected samples, the Wilcoxon test
is sufficient to support the conclusions reported. Besides, the Wilcoxon test is argued
to be statistically safer than the t-test for comparing classification algorithms over
multiple data sets (Demsˇar, 2006).
4.3 Results and discussion
Here we show the empirical results obtained by processing the data described below
by the method explained in Section 4.2 and comment on their relevance to questions
(Q1-Q3) formulated in the same place.
4.3.1 Classification tasks and data
Here we validate our methodology in biological classification tasks. In order to avoid
domain bias, we chose not to tackle overly special classification cases, the most prob-
lems distinguish between two tissue or cell types. We conducted our experiments
on 20 cross-species classification tasks based on gene expression samples downloaded
from the GEO. For ease of the experiment design, we take into the account following
constraints: (i) each problem contains two species-specific subtasks (e.g., the clas-
sification of Tuberculosis on Homo sapiens and Mus musculus data), (ii) only two
class classification problems are concerned, and (iii) exclusively the gene expression
platforms provided by Affymetrix are taken.
Set type Total Genes contained
Min Max Avg Median
FCF 605 1 48 5.53 3
Pathway 880 5 446 44.79 26
GO term 1454 6 2045 89.57 26
Table 4.1: Gene set statistics. The numbers in bold are independent of the specific
platforms measuring the expression data, being only determined by the respective
types of prior knowledge. The “Genes contained” columns capture statistics over all
involved platforms.
A detailed overview of the tasks including the number of samples in each class,
sample sources, and microarray platforms used for the measurement of the gene ex-
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pression is in Table 4.2. Table 4.1 shows statistics derived from the application of a
priori constructed gene sets onto the collected expression samples.
4.3.2 Reached results
The experiments revealed fundamental differences among the individual domains from
the point of view of their learnability and suitability for cross-species analysis. The
principal categories of learning curves and corresponding domain types are shown
in Figure 4.3. Figure 4.3a represents a domain that is easily learnable even with
a small number of training samples, the single-platform models show an excellent
accuracy and the accuracy remains good even when the single-platform models are
applied to the samples taken from the contrary platform. As expected, the cross-
platform model is excellent as well and the performance remains nearly absolute
when altering feature extraction methods. This domain is neutral when answering
the questions Q1 and Q2 and does not fit the question Q3. Figure 4.3b corresponds
to a domain that is learnable, but not trivially. Even though the classifiers less agree
across platforms and species, the generalization across platforms and genes helps.
The cross-platform classifier outperforms the single-platform ones and gene sets are
more accurate than single genes. Figure 4.3c demonstrates a learnable domain that
makes a counterexample to the previous one, i.e., it rather suggests negative answers
to all the concerned questions. Figure 4.3d shows a domain in which learning is
difficult, better than random classifiers can be reached in one organism only. The
generalization does not help, the models do not scale across platforms independently
of selected features. This domain is again neutral when answering the questions Q1
and Q2 and does not fit the question Q3.
Let us address the individual questions statistically following the detailed method-
ology given in the last paragraph of Section 4.2. The analysis concerns our pool of
domains as unbiased from the point of view of the above mentioned learnability cat-
egorization. The domains were constructed purely with the effort to meet the techni-
cal criteria such as the agreement in experimental conditions between platforms and
species, the representative sample sizes and keeping a limited set of platforms.
The question Q1 compares the single-platform and cross-platform classifiers. The
experiments proved that the cross-platform classifiers significantly outperform the
single-platform ones for small proportions of training examples (the p-value 4e−6 for
the 10% proportion of training samples, the p-value 0.02 for the 20% proportion of
training samples). For larger training sets, the single-platform classifiers show higher
accuracy than their cross-platform counterparts, however the margin is not large and
it is statistically insignificant (the mean difference for the largest proportion of 50%
samples used for training is 0.8%). The general recommendation is to prefer cross-
platform learning when the sample sizes are small (less than a few tens of samples
per platform). For larger sample sets, the general model can still be prefered but for
other reasons than the classification accuracy itself.
The question Q2 compares the classifiers based on original single gene expressions
with those based on activations of biologically meaningful gene sets. All the set of
15 comparative experiments (5 proportions and 3 different ways of gene set construc-
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tion) resulted in higher accuracy of gene set based classifiers (when averaged over 20
domains). When Q2 is posed without constraining the sample size, the gene sets can
be recommended and the recommendation is statistically supported (p-values 0.001
for pathways, 0.0002 for fluxes, and 0.004 for GO terms). When testing separately
for different sample sizes, all the gene set collections significantly outperform genes
for small sample sizes (the 10% and 20% proportion of training samples), fluxes keep
the statistically significant difference even for the largest sample sizes (p-value 0.002
for the 50% proportion of training samples). The general conclusion is to prefer the
gene-set-based models, the level of gene set abstraction (see the mean numbers in
Table 4.1) shall decrease with the increasing sample sizes.
Finally, to answer Q3 we identified domains where combining cross-species ex-
pression data is characterized by only rough similarity in phenotype markers. We
found 5 domains (Huntington’s Disease A and B, Retinoblastoma, Tuberculosis and
Breast Tumors) meeting the technical criteria mentioned in Section 4.2, i.e., the poor
generalization to the samples taken from the contrary platform and the large size
of gene based cross-platform model. The gene-set-based models met the assumption
that their generalization ability helps to improve the classification accuracy of gene-
based classifiers, but we could not statistically prove that the increase is larger than
the increase observed in an arbitrary domain. The number of domains is not large
enough.
4.4 Conclusions
To examine Hypothesis 1, we demonstrate the integration of multi-platform gene
expression data for predictive classification. When single-platform samples are rare,
integration of related (cross-platform and cross-species) data boosts classification per-
formance which supports the first hypothesis for the limited number of available sam-
ples only. In addition, we explored three ways of defining gene sets, including that
based on the notion of a fully coupled flux representing a trade-off between very spe-
cific genes and general metabolic pathways. In 20 cross-platform classification tasks,
we showed that the gene-set-based representation is useful for combining heteroge-
neous gene expression data. This may be for the sake of assembling a larger sample
set or to obtain general biological insights not limited to a particular organism. The
gene set features significantly outperform the gene-oriented ones in small sample sets
(the training sets containing 10% and 20% of available samples), the fluxes keep this
property even for the largest tested sample sets (the training sets containing 50% of
available samples). The pathways and GO terms also give higher predictive accu-
racies than the gene-based features, but the significance of this difference cannot be
proved on the selected significance level.
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(a) Easily learnable domain. Skeletal Muscle vs Blood
10 20 30 40 50
3 0
4 0
5 0
6 0
7 0
8 0
9 0
1 0
0
Gene
ff
fs
ss
sf
join
10 20 30 40 50
3 0
4 0
5 0
6 0
7 0
8 0
9 0
1 0
0
Flux
ff
fs
ss
sf
join
10 20 30 40 50
3 0
4 0
5 0
6 0
7 0
8 0
9 0
1 0
0
Pathway
ff
fs
ss
sf
join
10 20 30 40 50
3 0
4 0
5 0
6 0
7 0
8 0
9 0
1 0
0
GOterm
ff
fs
ss
sf
join
split [%]
a
c c
u
r a
c y
 [ %
]
(b) Two co-learnable subproblems. Skeletal Muscle vs Liver (XGE)
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(c) Learnable subproblems hardly co-learnable. Breast Tumors
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(d) Hardly learnable domain. Huntington’s Disease B
Figure 4.3: The principal categories of learning curves with references to the cor-
responding particular domains. The legend is as follows: (ff)—the single-platform
model learned on the training data from the (f)irst subproblem and tested on the
samples taken from the (f)irst subproblem, (fs)— the single-platform model learned
on the training data from the (f)irst subproblem and tested on the samples taken from
the (s)econd subproblem, (ss) and (sf)—defined likewise for the second subproblem,
(join)—the cross-platform model learned and tested on the samples merged from both
the subproblems.
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Chapter 5
A vanilla approach to descreasing
dimensionality
(Evaluation of Hypothesis 2 with state-of-the-art gene sets)
This chapter is dedicated to the evaluation of Hypothesis 2 on the state-of-the-art
gene sets commonly used for the set-level analysis.
Initial studies into the predictive performance of set-level classifiers have yielded
rather contradictory results (e.g., compare papers by Lee et al., 2008; Mramor et al.,
2010). Here we offer a more conclusive evaluation by testing various components
of the set-level framework within a large collection of machine learning experiments
on different data domains. Section 5.1 gives background for the evaluation of Hy-
pothesis 1 for the state-of-the-art gene sets. Section 5.2 specifies used methods and
data. Experimental results are divided into two sections: Section 5.3 contains general
performance evaluation of selected set-level aggregation techniques, and Section 5.4
contains additional experiments dealing with an evaluation of combination of machine
learning and feature selection either of set-level aggregated or unaggregated data and
analyses successful gene sets. In Section 5.5 we conclude and discuss the results.
5.1 Background
Lifting features to the set level incurs a significant compression of the training data
since the number of considered gene sets is typically much smaller than the number of
interrogated genes, as we already mentioned in Section 2.6. This compression raises
the natural question whether relevant information is lost in the transformation, and
whether the augmented interpretability will be outweighed by compromised predictive
accuracy. On the other hand, reducing the number of sample features may mitigate
the risk of overfitting and thus, conversely, contribute to higher accuracy. In machine
learning terms, reformulation of data samples through set-level features increases the
bias and decreases the variance of the learning process (see Section 2.4). An objective
of experiments in this chapter is to examine the second hypothesis; particularly, to
experimentally assess the combined effect of the two antagonistic factors (combin-
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ing feature selection techniques with the set-level transformation) on the resulting
predictive accuracy.
Another aspect of transforming features to the set level is that biological prior
knowledge is channeled into learning through the prior definitions of biologically
plausible gene sets. Among the goals of this chapter is to assess how significantly
such prior knowledge contributes to the performance of learned classifiers. We do
this assessment by comparing classification accuracy achieved with genuine curated
gene sets against that obtained with gene sets identical to the latter in number and
sizes, yet lacking any biological relevance. We also investigate patterns distinguishing
genuine gene sets particularly useful for classification from those less useful.
A further objective is to evaluate—from the machine learning perspective—some
representative statistical techniques proposed recently in the research on set-level gene
expression analysis. We select the Gene Set Enrichment Analysis (GSEA) method
(Subramanian et al., 2005) as a representant of the very popular technique among
biologists (despite its poor performance), a technique known as the Global test (Goe-
man and Bu¨hlmann, 2007) which is considered as one of the best performing methods,
and the SAM-GS algorithm (Dinu et al., 2007) also considered as a well performing
method (see Section 2.3 for the review). Informally, they rank a given collection
of gene sets according to their correlation with phenotype classes. The methods
naturally translate into the machine learning context in that they facilitate feature
selection (Liu and Motoda, 1998), i.e., they are used to determine which gene sets
should be provided as sample features to the learning algorithm. We experimen-
tally verify whether these methods work reasonably in the classification setting, i.e.,
whether learning algorithms produce better classifiers from gene sets ranked high by
the mentioned methods than from those ranking lower. We investigate classification
conducted with a single selected gene set as well as with a batch of high ranking
sets. Furthermore, we test how the three gene-set-specific methods compare to some
generic feature selection heuristics (information gain and support vector machine with
recursive feature elimination) known from machine learning.
To use a machine learning algorithm, a unique value for each feature of each train-
ing sample must be established. Set-level features correspond to multiple expressions
and these must therefore be aggregated. We comparatively evaluate three selected ag-
gregation approaches to cover different ways for set-level aggregation (see Section 2.6
for the complete methods review). The first (AVG) simply averages the expressions
of the involved genes. The value assigned to a sample and a gene set is independent
of other samples and classes. The other two, more sophisticated, methods (SVD,
SetSig) rely respectively on the singular value decomposition principle (e.g., Tomfohr
et al., 2005) and the so-called gene set signatures, which should perform better than
both other approaches (Mramor et al., 2010). In the latter two approaches, the value
assigned to a given sample and a gene set depends also on expressions measured in
other samples. Let us return to the initial experimental question concerned with how
the final predictive accuracy is influenced by the training data compression incurred
by reformulating features to the set level. As follows from the above, two factors
contribute to this compression: selection (not every gene from the original sample
representation is a member of a gene set used in the set-level representation, i.e.
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some interrogated genes become ignored) and aggregation (for every gene set in the
set-level representation, expressions of all its members are aggregated into a single
value). We quantify the effects of these factors on predictive accuracy. Regarding
selection, we experiment with set-level representations based on 10 best gene sets and
one best gene set, respectively, with both numbers chosen ad-hoc. The two options
are applied with all three selection methods (GSEA, SAM-GS, Global). We compare
the obtained accuracy to the baseline case where all individual genes are provided as
features to the learning algorithm, and to an augmented baseline case where a prior
feature-selection step is taken using the information gain heuristic. For each of the
selection cases, we further evaluate the contribution of the aggregation factor. This
evaluation is done by comparing all the three aggregation mechanisms (AVG, SVD,
SetSig) to the control case where no aggregation is performed at all; in this case,
individual genes combined from the selected gene groups act as features.
The key contribution of experiments in this chapter is thus a thorough evalua-
tion of a number of aspects and methods of the set-level strategy employed in the
machine learning context, entailing the reformulation of various, independently pub-
lished relevant techniques into a unified framework. Such a contribution is important
not only due to the current state of the art in microarray data analysis, where gener-
ally the need for methods evaluation seems to be higher than for their development
(see Section 2.5), but particularly also due to the inconclusive results of previous,
less extensive studies indicating both superiority (e.g., Lee et al., 2008) and inferior-
ity (Mramor et al., 2010, Sec. 4) of the set-level approach to classificatory machine
learning, with respect to the accuracy achievable by the baseline gene-level approach.
Our contributions are, however, also significant beyond the machine learning
scope. In the general area of set-level expression analysis, it is undoubtedly im-
portant to establish a performance ranking of the various statistical techniques for
the identification of significant gene sets in class-labeled expression data. This is
made difficult by the lack of an unquestionable ranking criterion—there is in general
no ground truth stipulating which gene sets should indeed be identified by the tested
algorithms. The typical approach embraced by comparative studies such as (Dinu
et al., 2007) is thus to appeal to intuition (e.g. the p53 pathway should be identified in
p53-gene mutation data). However legitimate such arguments are, evaluations based
on them are obviously limited in generality and objectivity. We propose that the pre-
dictive classification setting supported by the cross-validation procedure for unbiased
accuracy estimation, as adopted here, represents exactly such a needed framework
enabling objective comparative assessment of gene set selection techniques. In this
framework, results of gene set selection are deemed good if the selected gene sets
allow accurate classification of new samples. Through cross-validation, the accuracy
can be estimated in an unbiased manner.
5.2 Materials and methods
Here we first specify the methods adopted for gene set ranking, gene expression aggre-
gation, and for classifier learning. Next we present the datasets used as benchmarks
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in the comparative experiments. Lastly, we describe the protocol followed by the
experiments in this chapter.
5.2.1 Gene set ranking
Three statistics-based methods (GSEA, SAM-GS, and Global test) are considered
for ranking gene sets in this chapter. As inputs, all of the methods take a set G =
{g1, g2, . . . gp} of interrogated genes, and a set S of n expression samples where for
each si ∈ S, si = (e1,i, e2,i, . . . ep,i) ∈ Rp where ej,i denotes the (normalized) expression
of gene gj in sample si. The sample set S is partitioned into phenotype classes
S = C1 ∪C2 ∪ . . .∪Co so that Ci ∩Cj = {} for i 6= j. To simplify experiments in this
chapter, we assume binary classification, i.e., o = 2. A further input is a collection
of gene sets Σ such that for each Γ ∈ Σ it holds Γ ⊆ G. In the output, each of the
methods ranks all gene sets in Σ by their estimated power to discriminate samples
into the predefined classes.
Next we give a brief account of the three methods and refer to the original sources
for a more detailed description. In experiments, we used the original implementations
of the procedures as provided or published by the respective authors.
Gene set enrichment analysis (GSEA) (Subramanian et al., 2005)
This method tests a null hypothesis that gene rankings in a gene set Γ, according
to an association measure with the phenotype, are randomly distributed over the
rankings of all genes. It first sorts G by correlation with binary phenotype. Then
it calculates an enrichment score (ES) for each Γ ∈ Σ by walking down the sorted
gene list, increasing a running-sum statistic when encountering a gene gi ∈ Γ and
decreasing it otherwise. The magnitude of the change depends on the correlation of
gi with the phenotype. The enrichment score is the maximum deviation from zero
encountered in the random walk. It corresponds to a weighted Kolmogorov-Smirnov-
like statistic. The statistical significance of the ES is estimated by an empirical
phenotype-based permutation test procedure that preserves the correlation structure
of the gene expression data. GSEA was one of the first specialized gene-set analysis
techniques. It has been reported to attribute statistical significance to gene sets that
have no gene associated with the phenotype, and to have less power than other recent
test statistics (see Section 2.3.1).
SAM-GS (Dinu et al., 2007)
This method tests a null hypothesis that the mean vectors of the expressions of genes
in a gene set do not differ by phenotype. Each sample si is viewed as a point in
an p-dimensional Euclidean space. Each gene set Γ ∈ Σ defines its |Γ|-dimensional
subspace in which projections sΓi of samples si are given by coordinates correspond-
ing to genes in Γ. The method judges a given Γ by how distinctly the clusters of
points {sΓi |si ∈ C1} and {sΓj |sj ∈ C2} are separated from each other in the subspace
induced by Γ. SAM-GS measures the Euclidean distance between the centroids of
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the respective clusters and applies a permutation test to determine whether, and how
significantly, this distance is larger than that obtained if samples were assigned to
classes randomly.
The global test (Goeman and Bu¨hlmann, 2007)
The global test, analogically to SAM-GS, projects the expression samples into sub-
spaces defined by gene sets Γ ∈ Σ. In contrast to the Euclidean distance applied in
SAM-GS, it proceeds instead by fitting a regression function in the subspace, such
that the function value acts as the class indicator. The degree to which the two
clusters are separated then corresponds to the magnitude of the coefficients of the
regression function.
5.2.2 Expression aggregation
Three methods (SetSig, SVD, and AVG) are considered for assigning a value to a
given gene set Γ for a given sample si by aggregation of expressions of genes in Γ.
Averaging (AVG)
The first method simply produces the arithmetic average of the expressions ej,i of
all Γ genes 1 ≤ j ≤ p in sample si. The value assigned to the pair (si,Γ) is thus
independent of samples sj, i 6= j. Several authors utilized this approach (Abraham
et al., 2010; Azuaje et al., 2010; Guo et al., 2005; Liu et al., 2007a).
Singular value decomposition (SVD)
A more sophisticated approach was also employed by many authors (Bild et al., 2006;
Levine et al., 2006; Liu et al., 2007a; Tomfohr et al., 2005). Here, the value assigned to
(si,Γ) depends on expressions ej,i measured in sample si but, unlike in the averaging
case, also on expressions ej,k measured in samples sk, k 6= i. In particular, all samples
in the sample set S are viewed as points in the |Γ|-dimensional Euclidean space
induced by Γ the same way as explained in Section Gene set ranking. Subsequently,
the specific vector in the space is identified, along which the sample points exhibit
maximum variance. Each point sk ∈ S is then projected onto this vector. Finally,
the value assigned to (si,Γ) is the real-valued position of the projection of si on the
maximum-variance vector in the space induced by Γ.
Gene set signatures (SetSig)
Similarly to the SVD method, the SetSig (Mramor et al., 2010) method assigns to
(si,Γ) a value depending on expressions both in sample si as well as in other samples
sk, k 6= i. However, unlike in the previous two aggregation methods, here the value
also depends on the class memberships of these samples. In particular, SetSig confines
to two-class problems and the value (‘signature’) assigned to (si,Γ) can be viewed
as the Student’s unpaired t-statistic for the means of two populations of the Pearson
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correlation coefficients. The first (second) population studies correlation of si with
the samples from the first (second) class in the space induced by Γ. Intuitively,
the signature is positive (negative) if the sample correlates rather with the samples
belonging to the first (second) class.
5.2.3 Machine learning
We experimented with five diverse machine learning algorithms (1-nearest neighbor,
3-nearest neighbors, naive Bayes, decision tree, and support vector machine) to avoid
dependence of experimental results on a specific choice of a learning method. These
algorithms are explained in depth for example by Hastie et al. (2001). In experiments,
we used the implementations available in the WEKA software (Hall et al., 2009) with
the default settings. None of the methods below is in principle superior to the others,
although the first one prevails in predictive modeling of gene expression data and is
usually associated with high resistance to noise in data.
Support vector machine
Samples are viewed as points in a vector space with coordinates given by the values of
its features. A classifier is sought in the form of a hyperplane that separates training
samples of distinct classes and maximizes the distance to the points nearest to the
hyperplane (i.e. maximizing the margin) in that space or in a space of extended
dimension into which the original vector space is non-linearly projected.
1-nearest neighbor
This algorithm is a simple form of classification proceeding without learning a formal
data model. A new sample is always predicted to have the same class as the most
similar sample (i.e. the nearest neighbor) available in training data. We use the
Euclidean metric to measure the similarity of two samples.
3-nearest neighbors
This method is similar to 1-Nearest Neighbor, except that class is determined as one
prevailing among the three, rather than one, most similar samples in training data.
This method becomes superior to the previous one as noise in data exceeds a certain
threshold amount. The threshold value (and thus the optimal number of considered
neighbors) is in general not known.
Naive Bayes
A sample is classified into the class that is most probable given the sample’s fea-
ture values, according to a conditional probability distribution learned from training
data on the simplifying assumption that, within each class, all features are mutu-
ally independent random variables. Gene expression data usually deviate from this
assumption and consequently the method becomes suboptimal.
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Decision tree
A tree-graph model enables to derive a class prediction for a sample by following a
path from the root to a leaf of the tree, where the path is determined by outcomes
of tests on the values of features specified in the internal nodes of the tree. The tree
model is learned from training data and can also be represented as a set of decision
rules.
5.2.4 Expression and gene sets
We conduct our experiments using 30 public gene expression datasets, each containing
samples categorized into two classes. This collection contains both hard and easy
classification problems (see Figure 5.1). The individual datasets are listed in Table
5.1 and annotated in more detail in the supplemental material1.
Besides expression datasets, we utilized a gene set database consisting of 3272
manually curated sets of genes obtained from the Molecular Signatures Database
(MSigDB v3.0). These gene sets have been compiled from various online databases
(e.g. KEGG, GenMAPP, BioCarta).
For control experiments, we also prepared another collection of gene sets that is
identical to the latter in the number of contained sets and the distribution of their
cardinalities. However, the contained sets are assembled from random genes and have
no biological significance. The particular method used to obtain the randomized gene
sets is as follows. For sampling, we consider the set G of all genes occurring in some
of the genuine gene sets, formally G = {g|g ∈ Γ,Γ ∈ Σ}. Then, for each genuine gene
set Γ, we sample |Γ| genes without replacement uniformly from G to constitute the
counterpart random gene set Γ′.
5.2.5 Experimental protocol
Classifier learning in the set-level framework follows a simple workflow. Its perfor-
mance is influenced by several factors, each corresponding to a particular choice from
a class of techniques (such as for gene set ranking). We evaluate the contribution that
these factors make to the predictive accuracy of the resulting classifiers by repeated
executions of the learning workflow with varying the factors.
The learning workflow is shown in Fig. 5.3. Given a set of binary-labeled training
samples from an expression dataset, the workflow starts by ranking the provided set
of a priori-defined gene sets according to their power to discriminate sample classes.
The resulting ranked list is subsequently used to select the gene sets which form set-
level sample features. Each such feature is then assigned a value for each training
sample by aggregating the expressions in the gene set corresponding to the feature.
An exception to this pattern is the None alternative of the aggregation factor, where
expressions are not aggregated, and features correspond to genes instead of gene sets.
This alternative is considered for comparative purposes. Figure 5.2 illustrates the re-
sulting sample representation for four combinations of the selection and aggregation
1The material is available at http://ida.felk.cvut.cz/CESLT.
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Figure 5.1: Histograms of differential gene expression suggest the difficulty of the
individual domains. An easy domain is supposed to have a strongly left-skewed
histogram, while the difficult domains rather show a flat histogram. There is one plot
for each of 30 domains, x axis shows the p-value of differential expression, the y axis
gene frequency.
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alternatives. Next, a machine learning algorithm produces a classifier from the refor-
mulated training samples. Finally, the classifier’s predictive accuracy is calculated as
the proportion of samples correctly classified on an independent testing sample fold.
For compatibility with the learned classifier, the testing samples are also reformulated
to the set level prior to testing, using the same selected gene sets and aggregation
mechanism as in the training phase.
Seven factors along the workflow influence its result. The alternatives considered
for each of them are summarized in Table 5.2. We want to assess the contributions of
the first four factors (top in table). The remaining three auxiliary factors (bottom in
table) are employed to diversify the experimental material and thus increase the ro-
bustness of the findings. Factor 7 (testing fold) is involved automatically through the
adoption of the 10-fold cross-validation procedure (see, e.g., Chap. 7 in Hastie et al.,
2001). We execute the workflow for each possible combination of factor alternatives,
obtaining a factored sample of 792,000 predictive accuracy values.
While the measurements provided by the above protocol allow us to compare
multiple variants of the set-level framework for predictive classification, we also want
to compare these to the baseline gene-level alternative usually adopted in predictive
classification of gene expression data. Here, each gene interrogated by a microarray
represents a feature. This sample representation is passed directly to the learning
algorithm without involving any of the pre-processing factors (1-4 in Table 5.2). The
baseline results are also collected using the 5 different learning algorithms, the 30
benchmark datasets and the 10-fold cross-validation procedure (i.e., Factors 5-7 in
F3 F4 Example row
1 avg
Feature 1
avg{e11, . . . e1|Γ1|}
1 none
Feature 1 . . . Feature |Γ1|
e11 . . . e
1
|Γ1|
1:10 avg
Feature 1 . . . Feature 10
avg{e11, . . . e1|Γ1|} . . . avg{e101 , . . . e10|Γ10|}
1:10 none
Feature 1 . . . Feature
∑10
i=1 |Γi|
e11 . . . e
10
|Γ10|
Figure 5.2: Examples of sample representation generated with four combinations of
alternatives of factors 3 and 4 from Table 5.2. Shown for one sample (i.e. header +
one row) with eji denoting the expression of the i-th member of the j-ranked gene
set Γj. Non-exemplified combinations of the two factors are analogical to the cases
shown. The remaining considered factors do not influence the structure of sample
representation.
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Trainining fold
7. Testing fold
 2. Rank gene sets
 3. Select gene sets
 4. Aggregate
 5. Learn classifier
 Test classifier
 1. Prior gene sets
6. Data set
(Data Set \ Testing Fold)
Figure 5.3: The workflow of a set-level learning experiment conducted multiple times
with varying alternatives in the numbered steps. For compatibility with the learned
classifier, testing fold samples are also reformulated to the set level. The reformulation
is done using gene sets selected in Step 3 and aggregation algorithm used in Step 4.
The diagram abstracts from this operation.
Table 5.2 are employed). As a result, an additional sample of 1,500 predictive accuracy
values is collected for the baseline variant.
Finally, to comply with the standard application of the cross-validation procedure,
we average the accuracy values corresponding to the 10 cross-validation folds for
each combination of the remaining factors. The subsequent statistical analysis thus
deals with a sample of 79,200 and 150 measurements for the set-level and baseline
experiments, respectively, described by the predictive accuracy value and the values
of the relevant factors.
All statistical tests we conduct are based on the paired Wilcoxon test (two-sided
unless stated otherwise). For pairing, we always relate two measurements equal in
terms of all factors except for the one investigated. The stronger t-test is more
usual in analysis of predictive accuracy samples in literature but our preliminary
normality tests did not justify its application. Given the extent of the collected
samples, the Wilcoxon test was sufficient to support the conclusions reported. Besides,
the Wilcoxon test is argued (Demsˇar, 2006) to be statistically safer than the t-test
for comparing classification algorithms over multiple data sets.
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5.3 Main results
We first verified whether gene sets ranked high by the established set-level analysis
methods (GSEA, SAM-GS, Global) indeed lead to construction of better classifiers by
machine learning algorithms, i.e. we investigated how classification accuracy depends
on Factor 3 in Table 5.2. In the top panel of Fig. 5.4, we plot the average accuracy
for Factor 3 alternatives ranging 1 to 10 (top 10 gene sets), and n− 9 to n (bottom
10). The trend line fitted by the least squares method shows a clear decay of accuracy
as lower-ranking sets are used for learning. The bottom panel corresponds to Factor
3 values 1:10 (left) and n − 9 : n (right) corresponding to the situations where the
10 top-ranking and the 10 bottom-ranking (respectively) gene sets are combined to
produce a feature set for learning. Again, the dominance of the former in terms of
accuracy is obvious.
Given the above, there is no apparent reason why low-ranking gene sets should
be used in practical experiments. Therefore, to maintain relevance of the subsequent
conclusions, we conducted further analyses on the set-level experimental sample only
with measurements where Factor 3 (gene set rank) is either 1 or 1:10.
We next addressed the hypothesis that genuine gene sets constitute better features
than random gene sets, i.e. we investigated the influence of Factor 1 in Table 5.2.
Classifiers learned with genuine gene sets exhibited significantly higher predictive
accuracies (p = 1.4× 10−4, one-sided test) than those based on random gene sets.
Analyzed factors Alternatives #Alts
1. Gene sets (Sec. 5.2.4) Genuine, Random 2
2. Ranking algo (Sec. 5.2.1) GSEA, SAM-GS, Global 3
3. Set(s) forming features∗ 1, 2, . . . 10,
n− 9, n− 8, . . . n,
1:10, n− 9 : n 22
4. Aggregation (Sec. 5.2.2) SVD, AVG, SetSig, None 4
Product 528
Auxiliary factors Alternatives #Alts
5. Learning algo (Sec. 5.2.3) svm, 1-nn, 3-nn, nb, dt 5
6. Dataset (Sec. 5.2.4) d1 . . . d30 30
7. Testing Fold f1 . . . f10 10
Product 1500
∗ Identified by rank, n corresponds to the lowest ranking set, i:j denotes that all of gene sets
ranking i to j are used to form features.
Table 5.2: Alternatives considered for factors influencing the set-level learning work-
flow. The number left of each factor refers to the workflow step (Fig. 5.3) in which
it acts.
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Figure 5.4: The top panels show the plots for the average accuracy of Factor 3
alternatives ranging 1 to 10, and n − 9 to n. Average predictive accuracy tends to
fall as lower-ranking gene sets are used to constitute features (see text for details).
The trend lines shown in the top panels are the ones minimizing the residual least
squares. The bottom panel gives the accuracy boxplot for the batch experiments. 10
highest-ranking and the 10 lowest-ranking (respectively) gene sets are combined to
produce a feature set for learning. Again, the dominance of the former in terms of
accuracy is obvious. Each point in the top panels and each box plot in the bottom
panel follows from 16,000 learning experiments.
Given this result, there is a clear preference to use genuine gene sets over ran-
dom gene sets in practical applications. Once again, to maintain relevance of our
subsequent conclusions, we constrained further analyses of the set-level sample to
measurements conducted with genuine gene sets.
Working now with classifiers learned with high-ranking genuine gene sets, we
revisited Factor 3 to assess the difference between the remaining alternatives 1 and
1:10 corresponding respectively to more and less compression of training data. The
1:10 variant where sample features capture information from the ten best gene sets
exhibits significantly (p=3.5 × 10−5) higher accuracy than the 1 variant using only
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the single best gene set to constitute features (that is, a single feature if aggregation
is employed).
We further compared the three dedicated gene-set ranking methods, i.e. evaluated
the effect of Factor 2 in Table 5.2. Since three comparisons are conducted in this case
(one per pair), we used the Bonferroni-Dunn adjustment on the Wilcoxon test result.
The Global test turned out to exhibit significantly higher accuracy than either SAM-
GS (p = 0.0051) or GSEA (p = 0.0039). The difference between the latter two
methods was not significant.
Concerning the aggregation method (Factor 4 in Table 5.2), there are two ques-
tions of interest: whether there are significant differences in the performance of the
individual aggregation methods (SVD, AVG, SetSig), and whether aggregation in
general has a detrimental effect on performance. As for the first question, both SVD
and SetSig proved to outperform AVG (p=0.011 and p=0.03, respectively), while
the difference between SVD and SetSig is insignificant. The answer to the second
question turned out to depend on Factor 3 as follows. In the more compressive (1)
alternative, the answer is affirmative in that all the three aggregation methods re-
sult in less accurate classifiers than those not involving aggregation (p = 0.0061 for
SVD, p = 0.013 for SetSig and p=1.1 × 10−4 for AVG, all after Bonferroni-Dunn
adjustment). However, the detrimental effect of aggregation tends to vanish in the
less compressive (1:10) alternative of Factor 3, where only the AVG alternative in
comparison to None yields a significant difference (p=0.011). Table 5.3 summarizes
the main findings presented above.
Factor Alternatives
Better Worse
1. Gene sets Genuine Random
2. Ranking algo Global SAM-GS, GSEA
3. Sets forming features high ranking low ranking
1:10 (best ten sets) 1 (best set)
4. Aggregation∗ SetSig, SVD AVG
∗ Difference not significant if Factor 3 is 1:10.
Table 5.3: See Section 5.3 for details on how the conclusions were determined.
The principal trends can also be well observed through the ranked list of method-
ological combinations by median classification accuracy, again generated from mea-
surements not involving random or low-ranking gene sets. This is shown in Table
5.4. Position 17 refers to the baseline method where sample features capture expres-
sions of all genes and prior gene set definitions are ignored. In agreement with the
statistical conclusions above, the ranked table clearly indicates the superiority of the
Global test for gene-set ranking, and of using the 10 best gene sets (i.e., the 1:10
alternative) to establish features rather than relying only on the single best gene set.
It is noteworthy that all four combinations involving the Global test and the 1:10
alternative (i.e., ranks 1, 2, 4, 5) outperform the baseline method.
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Rank Methods Accuracy
Sets Rank. algo Aggrgt Median Avg σ Iqr
1 1:10 Global SVD 89.2 79.5 18.9 33.2
2 1:10 Global None 88.3 81.0 17.7 31.3
3 1 Global None 87.8 80.7 17.5 31.0
4 1:10 Global SetSig 87.4 81.1 16.5 26.1
5 1:10 Global AVG 85.6 78.7 18.4 32.6
6 1:10 SAM-GS SetSig 85.4 79.9 17.1 30.2
7 1:10 SAM-GS None 84.6 80.1 17.3 30.7
8 1 Global SVD 83.8 77.9 20.1 34.3
9 1:10 GSEA SetSig 83.4 78.3 16.7 26.3
10 1:10 GSEA None 82.3 80.0 16.8 30.4
11 1:10 SAM-GS SVD 79.9 77.1 18.0 32.1
12 1:10 GSEA SVD 79.2 77.2 17.7 31.7
13 1:10 GSEA AVG 79.1 76.4 16.9 31.9
14 1 SAM-GS None 78.3 76.0 15.3 26.3
15 1 Global SetSig 77.5 75.9 15.1 23.5
16 1 GSEA None 76.7 75.6 16.3 29.5
17 baseline (all genes used) 75.5 76.6 18.4 33.5
18 1 SAM-GS SetSig 75.0 74.7 14.2 18.9
19 1 Global AVG 72.7 73.8 17.6 31.1
20 1:10 SAM-GS AVG 72.5 73.8 15.9 26.0
21 1 GSEA SetSig 70.2 72.6 17.0 26.8
22 1 GSEA AVG 69.6 68.1 12.8 22.4
23 1 GSEA SVD 69.5 71.9 16.3 28.2
24 1 SAM-GS SVD 69.0 69.5 15.7 21.3
25 1 SAM-GS AVG 67.3 67.0 11.4 15.5
Table 5.4: Ranking of combinations of gene set methods by median predictive ac-
curacy achieved on 30 datasets (Section 5.2.4) with 5 machine learning algorithms
(Section 5.2.3) estimated through 10-fold cross-validation (i.e. 1,500 experiments per
row). The columns indicate, respectively, the resulting rank by median accuracy, the
gene sets used to form features (1—the top ranking set, 1:10—the top ten ranking
sets), the gene set selection method, the expression aggregation method (see Section
5.2 for details on the latter 3 factors), and the median, average, standard deviation
and interquartile range of the accuracy.
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While intuitive, rankings based on median accuracy over multiple datasets may,
according to Demsˇar (2006), be problematic as to their statistical reliability. There-
fore, we offer in Table 5.5 an alternative ranking of the 19 methods that avoids
mixtures of predictive accuracies from different datasets. Here, the methods were
sub-ranked on each of the 150 combinations of 30 datasets and 5 learning algorithms
by cross-validated predictive accuracy achieved on that combination. The 150 sub-
ranks were then averaged for each method, and this average dictates the ranking
shown in the table. In this ranking, the baseline strategy improves its rank to Posi-
tion 5. The superiority of classifiers learned from 10 gene sets selected by the Global
test, as formerly noted for Table 5.4, continues to hold in the alternative ranking
underlying Table 5.5.
5.4 Additional analyses
5.4.1 Generic feature selection
In the set-level classification framework, gene sets play the role of sample features.
Therefore the three gene-set ranking methods (GSEA, SAM-GS, Global) are em-
ployed for feature selection conducted in the learning workflow. While the latter
three methods originate from research on gene expression analysis, generic feature
selection methods have also been proposed in machine learning research (Liu and
Motoda, 1998). It is interesting to compare the latter to the gene-expression-specific
methods. To this end, we consider two approaches. Information Gain (IG) (Mitchell,
1997) is a feature-selection heuristic popular in machine learning. In brief, IG mea-
sures the expected reduction in class-entropy caused by partitioning the given sample
set by the values of the assessed feature. One of the main disadvantages of IG is that
it disregards potential feature interactions. Support Vector Machine with Recursive
Feature Elimination (SVM-RFE) (Guyon et al., 2002) is a method that ranks fea-
tures by repetitive training of a SVM classifier with a linear kernel while gradually
removing the feature with the smallest input classifier weight. This approach does
not assume that features are mutually independent. On the other hand, it natu-
rally tends to select a feature set that maximizes the accuracy of the specific kind
of classifier (SVM). For computational reasons (large number of runs and genes), we
removed several features at a time (F × 2−i features in the i-th iteration, where F
is the original number of features). Guyon et al. (2002) mention such a modification
with the caveat that it may be at the expense of possible classification performance
degradation.
In the present context, generic feature selection can be applied either on the gene
level or on the set level. We explored both scenarios.
The gene-level application produces a variant of the baseline classifier (position
17 in Table 5.4, position 5 in Table 5.5) where, however, the learning algorithm only
receives features corresponding to genes top-ranked by the feature selection heuristic,
rather than all measured genes. The selection is thus based only on the predictive
power of the individual genes and ignores any prior definitions of gene sets. The
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Rank Methods Avg Subrank
Sets Rank. algo Aggrgt
1 1:10 Global None 15.3
2 1:10 Global SetSig 15.7
3 1 Global None 16.3
4 1:10 GSEA None 16.7
5 baseline (all genes used) 16.8
6 1:10 Global SVD 17.0
7 1:10 SAM-GS None 17.2
8 1:10 SAM-GS SetSig 17.6
9 1:10 Global AVG 18.6
10 1 Global SVD 19.4
11 1:10 GSEA SetSig 19.9
12 1:10 GSEA SVD 20.1
13 1:10 SAM-GS SVD 20.8
14 1:10 GSEA AVG 22.1
15 1 Global SetSig 22.2
16 1 SAM-GS None 23.0
17 1 SAM-GS SetSig 23.8
18 1 GSEA None 23.9
19 1 Global AVG 24.6
20 1:10 SAM-GS AVG 25.5
21 1 GSEA SVD 26.7
22 1 GSEA SetSig 26.8
23 1 SAM-GS SVD 28.3
24 1 SAM-GS AVG 30.3
25 1 GSEA AVG 30.9
Table 5.5: Ranking of all combinations of methods in terms of average subrank.
Subranking is done on each of the 150 combinations of 30 datasets and 5 learning
algorithms by cross-validated predictive accuracy. Column descriptions are as in
Table 5.4.
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question of how many top-ranking genes should be used for learning is addressed
as follows. We want to make the resulting predictive accuracy comparable to that
obtained in the main (set-level) experimental protocol, in particular to the 1 and 1:10
alternatives of Factor 3. The median of the number of unique genes present in the
selected gene sets in the 1 (1:10, respectively) alternative is 22 (228). Therefore we
experiment respectively with 22 and 228 genes top-ranked by generic feature selection.
The results are shown in Table 5.6. Comparing the latter to Tables 5.4 and 5.5, we
observe that both variants improve the baseline and in fact produce the most accurate
classifiers (IG outperforms the set-level approaches, SVM-RFE is comparable with
the Global test). SVM-RFE does not outperform IG in general, but it does so in the
special case when SVM is used as the learning algorithm.
While the gene-level application of feature selection results in accurate classifiers,
the obvious drawback of this approach is that the genes referred in such produced
classifiers cannot be jointly characterized by a biological concept. This deficiency is
removed if feature selection is instead applied on the set level, i.e. to rank apriori-
defined gene sets. This way, the selection methods essentially become the fourth and
fifth alternative of Factor 2 (see Table 5.2) up to the following nuance. While the
dedicated gene-set methods (GSEA, SAM-GS, Global) score a feature (gene set) by
the expressions of its multiple member genes, IG and SVM-RFE score a feature by
the single real value assigned to it, i.e., by the aggregated expressions of the member
genes. Therefore, when using the generic feature selection, the aggregation step in
the experimental workflow (Figure 5.3) must precede the ranking step. The results
of applying IG and SVM-RFE on the set level are shown in Table 5.7. Comparing
again to Tables 5.4 and 5.5, both IG and SVM-RFE are outperformed by the Global
test (Wilcoxon test, p=0.017).
5.4.2 Successful gene sets
We also explored patterns distinguishing gene sets particularly useful for classification
from other employed gene sets sourced from the Molecular Signatures Database. To
# Method # Selected Genes Accuracy Avg Subrank
Median Avg σ Iqr
IG 22 90.2 81.5 18.1 30.7 15.0
IG 228 89.8 82.0 17.9 30.3 14.5
SVM-RFE 228 88.3 82.3 16.7 28.5 16.4
SVM-RFE 22 88.0 82.1 17.2 30.4 16.2
Table 5.6: Performance of the baseline classification method equipped with a feature-
selection step prior to learning. Features (genes) are ranked by the information gain
and SVM-RFE heuristics. The number of selected top-ranking genes (22 and 228,
respectively) corresponds to the mean number of unique genes acting in gene sets
selected in the 1 and 1:10 (respectively) alternatives of the set-level workflow.
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Sets Methods Accuracy Avg Subrank
Selection Aggrgt Median Avg σ Iqr
1:10 SVM-RFE SVD 88.3 80.6 17.3 33.0 17.6
1:10 IG SVD 87.0 79.0 18.7 31.6 17.4
1:10 IG AVG 84.6 78.2 18.6 33.4 18.7
1:10 SVM-RFE AVG 84.4 79.2 17.1 31.2 19.2
1:10 SVM-RFE SetSig 82.5 78.7 17.0 31.2 19.4
1 IG SVD 80.8 76.3 17.7 33.1 22.5
1:10 IG SetSig 80.0 77.1 17.4 33.2 20.8
1 SVM-RFE SetSig 71.8 73.7 15.8 26.4 23.3
1 SVM-RFE SVD 71.5 74.4 17.4 30.3 23.0
1 IG AVG 70.9 74.0 18.6 33.1 24.1
1 SVM-RFE AVG 70.8 72.5 15.4 26.6 24.4
1 IG SetSig 66.2 68.8 16.2 25.0 28.9
Table 5.7: Performance of the set level classification strategy using the information
gain and SVM-RFE heuristics for ranking gene sets. Column descriptions are as in
Table 5.4.
this end, we defined three groups of gene sets. The first group referred to as full
comprises the entire set of 3028 gene sets obtained from the database (gene sets
containing fewer than 5 or more than 200 genes were discarded). The second group
referred to as selected consists of the 900 gene sets ranked high (1st to 10th) by any
of the three selection methods for any of the dataset. The third group referred to as
successful is a subset of the selected group and contains the 210 gene sets acting in
classifiers that outperformed the baseline.
We investigated two kinds of properties of the gene sets contained in the three
respective groups. First, we considered the gene set type as defined in the Molecular
Signatures Database. The gene sets belonging to the category of chemical and genetic
perturbations (CGP) were more frequently selected and also more frequently appeared
in the successful group than the gene sets representing canonical pathways (CP) (full:
CGPs 73%, CPs 27%, selected: CGPs 88%, CPs 12%, successful: CGPs 88%, CPs
12%). Second, we considered four possible notions of gene set size: i) nominal size (the
gene set cardinality), ii) effective size (number of genes from the gene set measured
in the dataset), iii) number of PCA coefficients capturing 50% of expression variance
in the gene set, iv) as in iii) but with 90% variance. As follows from Table 5.8, the
successful group contains smaller gene sets than the other two groups, and this trend
is most pronounced for the Global test ranking method (Mann-Whitney U test, the
successful group versus the full group, Bonferroni adjustment: Effective size p=0.084,
PCA 90% p=0.0039)
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Group Selection Statistic Nominal size Effective size PCA 50% PCA 90%
Full None
mean 71.7±1.7 40.9±0.7 4.4±0.03 16.7±0.14
median 37.0 28.1 4.1 15.3
Selected
all
mean 62.5±2.7 47.8±1.9 3.8±0.08 15.1±0.35
median 33.5 27.0 3.4 13.4
Global median 32.0 25.5 3.3 12.8
GSEA median 34.0 27.0 3.4 13.7
SAM-GS median 40.5 28.0 3.7 14.3
Successful
all
mean 56.9±4.4 39.2±2.9 4.3±0.14 14.7±0.56
median 31.0 21.0 3.9 12.6
Global median 22.0 18.5 3.8 11.7
GSEA median 37.0 27.5 4.3 14.2
SAM-GS median 30.5 22.5 4.0 12.7
Table 5.8: Mean and median sizes of gene sets partitioned into three groups (see
Section Successful gene sets for details.
5.5 Conclusions
We have established the following main conclusions by executing various experiments
on 30 gene expression data classification problems.
1. State-of-the-art gene set ranking methods (GSEA, SAM-GS, Global test) per-
form reasonably as feature selectors in the machine learning context in that high
ranking gene sets outperform (i.e., constitute better features for classification
than) those that are low ranking.
2. Genuine curated gene sets from the Molecular Signature Database outperform
randomized gene sets. Smaller gene sets and sets pertaining to chemical and
genetic perturbations were particularly successful.
3. For gene set selection, the Global test (Goeman and Bu¨hlmann, 2007) outper-
forms SAM-GS (Dinu et al., 2007), GSEA (Subramanian et al., 2005) as well
as the generic information gain heuristic (Mitchell, 1997) and the SVM-based
recursive feature elimination approach (Guyon et al., 2002).
4. For aggregating expressions of set member genes into a unique feature value,
both SVD (Tomfohr et al., 2005) and SetSig (Mramor et al., 2010) outperform
arithmetic averaging (e.g., Holec et al., 2009b).
5. Using the top ten gene sets to construct features results in better classifiers than
using only the single best gene set.
6. The set-level approach using the top ten genuine gene sets as ranked by the
Global test outperforms the baseline gene-level method in which the learning
algorithm is given access to expressions of all measured genes. However, it is
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outperformed by the baseline approach if the latter is equipped with a prior
feature selection step.
Conclusion 1 is rather obvious and was essentially meant as a preparatory check.
The first statement of Conclusion 2 is not obvious, since constructing randomized
gene sets in fact corresponds to the machine learning technique of stochastic feature
extraction (Ho, 1998) and as such may itself contribute to learning good classifiers.
Nevertheless, relevant prior knowledge resting in the prior definition of biologically
plausible gene sets contributes further to increasing the predictive accuracy. Conclu-
sions 3 and 4 are probably the most significant for practitioners in set-level predictive
modeling of gene expression as so far there has been no clear guidance for making the
right choice.
Concerning Conclusion 3, the advantages of the Global test were argued in Goe-
man and Bu¨hlmann (2007) but not supported in terms of the predictive power of
the selected gene sets. As for conclusion 4, the SetSig technique was introduced and
tested in Mramor et al. (2010), appearing superior to both averaging and a PCA-
based method which is conceptually equivalent to the SVD method (Tomfohr et al.,
2005). However, owing to the limited experimental material in Mramor et al. (2010),
the ranking was not confirmed by a statistical test. Here we confirmed the superiority
of SetSig with respect to averaging; however, the difference between the performance
of SetSig and SVD was not significant.
A further remark concerns the aggregation methods mentioned. All three of them
are applicable to any kind of gene set collections, whether these are derived from
pathways, the GO or other sources of prior knowledge. The downside of this generality
is that substantial information available for specific kinds of gene sets is ignored.
Conclusion 5 is not entirely surprising. Relying only on a single gene set entails too
large an information loss and results in classifiers less accurate than those using the
ten best gene sets. Note that in the single gene set case, when aggregation is applied
(SVD, AVG or SetSig), the sample becomes represented by only a single real-valued
feature and learning essentially reduces to finding a threshold value for it. To verify
that more than one gene set should be taken into account, we tested the 10-best-sets
option and indeed it performed better.
A straightforward interpretation of Conclusion 6 is that the set-level framework
is not an instrument for boosting predictive accuracy, and—therefore—we can reject
Hypothesis 2 for the used state-of-the-art gene set collections, data, and methods.
However, set-level classifiers have a value per se, just as set-level units are useful in
the standard differential analysis of gene expression data. In this light, it is important
that with a suitable choice of techniques, set-level classifiers do achieve an accuracy
competitive with conventional gene-level classifiers.
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Chapter 6
A more advanced approach to
decreasing dimensionality
(Evaluation of Hypothesis 2 with originally designed gene sets)
This chapter is dedicated to the evaluation of Hypothesis 2 on bacteria, whose
hereditary information and structural complexity is much simpler than complexity
of prokaryotic cells, we primarily focus here on different specific type of gene set
collections with potential to boost predictive accuracy.
The chapter is organized as follows. Section 6.1 specifies background for exami-
nation of this hypothesis for the novel gene set collections. In Section 6.2 we give an
overview of used data, prior knowledge, and methods. Sections 6.3 and 6.4 provide
results and conclude experiments, respectively.
6.1 Background
Given the implied reduction in sample dimensionality, the set-level approach should
lead to a decreased risk of overfitting potentially resulting in improved accuracy of
induced predictive models. In the previous chapter, we have analyzed this reduction
using the traditional gene set collections based on pathways and GO terms, and con-
cluded that we can reject Hypothesis 2 for this type of gene set collections, which is
also in concordance with the latest published results (Abraham et al., 2010; Mramor
et al., 2010; Staiger et al., 2012). Specifically, it was shown that reducing the dimen-
sionality through a standard feature (gene) selection method applied on the original
gene-level representation leads to accuracies higher than those achieved with the gene
set representation.
We presume that the lack of predictive accuracy improvements observed in the
previous studies was due to the adoption of unsuitable gene set definitions.
To define biologically relevant gene sets, we rely on the following two observations:
1. Expression of individual genes does not correlate very well with the amount of
the coded proteins.
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2. High correlation can be expected between expressions of genes which share
several activating regulatory proteins (transcription factors).
As for the first observation, that there is—generally—only a modest correlation
between the amounts of mRNAs on one hand and corresponding proteins on the other
hand, this is hypothesised to be mainly due to the presence of post-transcriptional
and post-translational modifications and other regulatory interactions (see, e.g., the
review in Vogel and Marcotte, 2012). For bacteria, post-transcriptional rather than
post-translational regulatory mechanisms control cellular mRNA to protein abun-
dance ratios (Maier et al., 2011). Furthermore, the correlation of the abundance of
proteins and the expression measured by microarrays is even smaller because mi-
croarrays are not a quantitative platform; however, the measured mRNA expression
is highly correlated with the amount of present transcripts (Canales et al., 2006).
The second observation is a rather obvious implication of gene regulatory mecha-
nisms but was also confirmed experimentally in specific studies concerning operons.
Operons are contiguous clusters of genes which are transcribed into mRNA as a single
unit. Thus, genes in the same operon share some of their regulatory proteins and, by
the second assumption above, they should be highly correlated. This is supported, for
example, by an improvement of gene expression estimations using operon structure
(Xiao et al., 2006) and relatively higher consistence of genes contained in the same
operon as opposed to gene groups defined by a common GO term or KEGG path-
way membership (Tintle et al., 2012). We recall here that the GO terms and KEGG
pathways represents very popular gene set collections previously used for gene-set-
level predictive classification (e.g., Abraham et al., 2010; Mramor et al., 2010; Staiger
et al., 2012), and this type of prior knowledge is also frequently used in other tasks like
gene enrichment analysis (Huang et al., 2009; L´ıbalova´ et al., 2012), gene functional
clustering (Krejn´ık and Kle´ma, 2012; Mitra and Ghosh, 2012), and pattern mining
(Kle´ma et al., 2006; Leyritz et al., 2008).
6.2 Methods
This section is organized as follows. First, we explain the gene sets used in our study.
Then we briefly describe the machine learning scenarios which we use to assess the
performance of the new types of gene sets, and also explain how gene sets are used to
aggregate features of gene expression samples. After that, we describe the procedure
we conducted to prepare training data. Finally, we describe our simple two-step
experimental protocol.
6.2.1 Gene set collections
We introduce several novel types of gene sets which will be based on the following
two assumptions. First, the expression of genes which are regulated by the same
sets of activating and repressing regulatory genes should be more correlated than
random sets of genes. Second, their aggregated expression should be correlated with
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(a) (b)
Figure 6.1: Example of operon based gene sets: (a) The operon bcsABZC con-
tains genes bcsC, bcsZ, bcsB, bcsA, and contains transcription units bcsABZC and
bcsBZ. (b) OPRgs chunks are consecutive set of genes in operons which are always
co-transcribed.
the presence of the regulatory gene products in their active form, which, in turn,
should be associated with some phenotype. In order to test the extent to which it is
necessary to consider sets of genes with exactly the same regulation, we define several
types of gene sets in which this condition is relaxed in various ways.
There are two possible ways to construct gene sets according to the described
logic. The first possibility is to exploit the known operon structure of prokaryotic
genome, for which we do not need to know the exact regulatory network. The second
possibility is to use information about the regulatory network.
The actual instantiation of the gene sets that we use is derived from the tran-
scriptional regulation network of Escherichia coli K-12 as described in RegulonDB
(ver. 8.2) (Salgado et al., 2013).
Gene sets based on the structure of operons
The gene sets based on the operon structure are based on the following biological
intuition based on the way DNA is transcribed into mRNA which is specific for
prokaryotes. In prokaryotes, genes are organized into contiguous clusters called oper-
ons which are transcribed into mRNA as a single units. Some operons may also
have multiple promoters, possibly located even inside the operon (which means that
sometimes only a partial group of genes of the operon may be transcribed).
Operon genes (OPRgs). We can expect genes in an operon to be more correlated
than randomly selected genes and, therefore, it makes sense to try to use them as so
called operon gene sets.
Transcriptional unit genes (TUgs). Similar gene sets based on organization of
genes in prokaryotic genomes are transcription unit (TU) gene sets which actually
include also all operons. A transcription unit is a group of genes transcribed from a
single promoter. Unlike operons, transcription units may overlap and one transcrip-
tion unit can be contained in another transcription unit (Fig. 6.1a). Similarly, as for
operons, we may expect the expression of genes in a transcription unit to be more
correlated than for a random group of genes.
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Non-interrupted subsequences of operons (OPRgs chunks). However, it
may still be the case that only a part of a transcription unit is transcribed into
mRNA (already because operons are also transcription units). Therefore, we also
consider a third kind of this type of gene sets: operon chunks which are contiguous
subsets of operons such that there is no promoter or terminator located between two
genes contained in an operon chunk (Fig. 6.1b). It follows that the expression of
genes in an operon chunk should be highly correlated.
(a) (b)
Figure 6.2: Example of transcription factor based gene sets: (a) A transcription
factor Fur regulates altogether 130 genes including positively regulated genes (e.g.,
sucA, sucD) and negatively regulated genes (e.g., cyoB, sucB, sucC, entD); all these
regulated genes constitute a gene set. (b) A complex regulon defined by genes sucA,
sucD, sucB, and sucC can be divided into two strict regulons defined by two pairs of
genes (sucA, sucD) and (sucB, sucC). The all three mentioned regulons are regulated
only by a common set of transcription factors CRP, ArcA, IHF, Fur, and FNR.
Gene sets based on transcription factors
The following gene sets are based directly on characterizing groups of genes with the
same regulation.
Transcription factor regulated genes (TFgs). The simplest of this type of
gene sets are TF gene sets (Fig. 6.2a) which are composed of sets of genes having a
regulating transcription factor in common.
Gene sets based on regulons (REGgs). Another type of gene sets are Regulon
gene sets which are based on the notion of regulon from Maas (1964). A regulon is
a set of genes where each of its element is regulated by the same set of transcription
factors. Regulon gene sets are gene sets corresponding to regulons. Using description
of the regulatory network, we group together genes regulated by the same set of
transcription factors, the type of relations is ignored here (Fig. 6.2b).
Strict REGgs (Strict REGgs). The only difference between the regular and strict
REGgs gene sets is that the latter group only such genes which share the same type
of the regulatory interaction with each of the transcription factors (Fig. 6.2b). This
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formulation is based on the definition of strict regulons from Gutie´rrez-R´ıos et al.
(2003)
One may expect quite reasonably that the regulons and strict regulons perform
better than TF gene sets. Let us see why on an example. Let us have genes g1, g2
and g3 which are all regulated by a transcription factor t which is an activator for
all of these three genes. This means that g1, g2 and g3 form a TF gene set according
to our definition. If t was the only gene regulating any of the three genes then there
would be basically no problem and we could expect that the presence of a sufficient
amount of proteins coded by t in their active form would imply increased expression
of all the three genes. However, if g1 was also regulated by a repressor gene t2 and the
repressor t2 was present in its active form then g1 would not probably have increased
expression. This issue is solved by using regulons and strict regulons. There may still
be problems when using non-strict regulons as gene sets because non-strict regulons
do not take into account the role of the regulatory genes (whether they are activators
or repressors). For example, if we wanted to aggregate expression of genes in a regulon
by averaging them then we might hit upon a problem similar to the following one. Let
us have a regulon corresponding to genes regulated by only one transcription factor
t′. Let us suppose that this regulon consists only of two genes g′1 and g
′
2 where g
′
1 is
repressed by t′ whereas g′2 is activated by t
′. Now, if t′ is present in its active form
then we might expect the expression of g′1 to be low and the expression of g
′
2 to be
high. So we cannot expect their average expression to be very correlated with the
presence of t′ in its active form. However, this potential problem can be solved by
using strict regulons instead of non-strict regulons, as strict regulons take the role of
the regulatory genes into account.
Gene sets based on KEGG pathways and GO terms. The GO terms and
KEGG pathways are often used as specifications of gene sets in order to incorporate
prior knowledge into analysis of gene expression data. Here they mainly serve as
reference in order to compare with the results reached with the operon-based and
TF-based gene sets. We extracted these gene sets from the R package Genome wide
annotation for Escherichia coli strain K12 (version 2.9.0).
Randomized gene sets In addition to gene sets based on organization of prokary-
otic genomes or gene sets based on structure of the prokaryotic regulatory networks,
we defined also their randomized counterparts (denoted by the prefix Fake). For a
given type of gene sets (e.g., transcription-unit gene sets), genes in the randomized
gene sets are shuﬄed among all gene sets, thus, proportions of the gene sets remain
unchanged. The reason why we introduce these fake gene sets is to see whether the
knowledge present implicitly in our gene sets is the actual factor influencing accuracy
of the classification method exploiting these gene sets. If randomly selected gene sets
with the same cardinalities performed equally well or even better then this would
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mean that what determines accuracy of the method the most is not the implicitly
captured information about structure of the regulatory network.
# sets # genes Min. Median Mean Max.
baseline on TU genes 4524
baseline on TF genes 1685
baseline on GO+KEGG genes 2734
TUgs 3213 4524 1 1 1.685 16
OPRgs 2649 4524 1 1 1.708 16
OPRgs chunks 3164 4524 1 1 1.430 12
GO+KEGG 260 2734 1 12 31.830 847
TFgs 186 1685 1 7 24.720 534
REGgs 459 1685 1 2 3.671 61
Strict REGgs 541 1685 1 2 3.115 51
Table 6.1: Gene set collection types properties.
6.2.2 Learning and set-level aggregation methods
In order to evaluate usefulness of the gene sets that we propose in this chapter, we
performed machine learning experiments in which a machine learning algorithm was
used to learn a classifier for predicting phenotype from measured gene expressions.
We used support vector machine learning algorithm (Cortes and Vapnik, 1995). For
a support vector machine, samples are viewed as points in a vector space with coor-
dinates given by the values of the sample’s features. A classifier is sought in the form
of a hyperplane that separates training samples of distinct classes and maximizes the
distance to the points nearest to the hyperplane (i.e., maximizing the margin) in that
space. We used implementation from the R package e1071, version 1.6-1.
Normally, features of a sample would be the expressions of the individual genes.
However, in set-level methods, features are aggregates of expressions of genes in pre-
specified gene sets. Thus, an important component of set-level methods is data aggre-
gation which computes a single real number representing the aggregated expression of
genes in a gene set, i.e., the input to an aggregation procedure is a vector of expres-
sions of genes in a gene set and its output is one real number which should represent
the expression of the genes in the gene set, similarly like in the previous chapter.
There are many aggregation methods (Section 2.6). Due to very low number of sam-
ples in the datasets with which we work, we represent the aggregated expression of
a gene set by arithmetic average. We should also note that aggregation using arith-
metic average is very well suited for the types of gene sets that we defined because
the expression of genes in these gene sets is expected to be positively correlated
A technique which is often used to reduce the number of features used by learnt
classifiers is feature selection. In principle, feature selection may increase predictive ac-
curacy but it may also lead to decorrelation of the error estimated by cross-validation
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and the true error (Hanczar et al., 2007). We performed experiments with feature
selection in which features are either expression of individual genes or aggregated ex-
pressions of gene sets or a combination of both. We used SVM-RFE feature selection
(Guyon et al., 2002) which is especially suited for use in conjunction with support
vector machines. We used the faster version of SVM-RFE which is also described in
Guyon et al. (2002). When performing the leave-one-out cross-validation, the feature
selection procedure was always performed only on the training folds.
6.2.3 Gene expression data and prior knowledge
The results presented here are based on a large experiment involving more than
70 small microarray gene expression datasets measured in the bacteria Escherichia
coli. We selected this popular model organism for the following reasons. First, it
is estimated that about 2/3 of its transcriptional regulatory proteins and most of
their targets are already known and described in the publicly available database
RegulonDB1 (Salgado et al., 2013). Second, there is a reasonable number of gene-
expression datasets for Escherichia coli available in the Gene Expression Omnibus
database (Edgar et al., 2002). Third, organization of genomes and transcriptional
networks is much simpler in prokaryotic organisms such as Escherichia coli than in
eukaryotic organisms and, therefore, it seems more reasonable to try to devise new
methods for prokaryotic organisms and then to try to extend them to eukaryotes
rather than the reverse way.
We downloaded 10 largest series of gene expression data for Escherichia coli K12
with as many measured samples as possible (as available in the GEO in April 2013).
To have homogeneous data, we limited ourselves to Affymetrix microarray platforms
only; particularly, GeneChip R© E. coli Antisense Genome array and GeneChip R© E.
coli Genome 2.0 array. The series were downloaded from the GEO (see Table 6.2
for series identifiers). Two of the series could be possibly confounding, because they
were used for the development of the RegulonDB; therefore, we excluded them. We
checked that the remaining series were not used in the development of RegulonDB.
Each of the series contain samples corresponding to several phenotypes (Table 6.2
for number of phenotypes in the series). In order to obtain datasets for learning
problems with two classes, we generated a set of non-overlapping datasets from the
available series in the following way. For each of the series, we considered all pairs
of phenotypes as candidate datasets. From this basic pool of candidate datasets we
randomly selected 71 datasets which have unique phenotypes (no phenotype appears
more than once in these 71 datasets and thus no sample can appear in two different
datasets), we call this set of datasets non-overlapping datasets (N/O datasets). We
also generated an auxiliary set of 100 possibly overlapping datasets (AUX) not con-
tained in the N/O datasets which is used only for facilitating unbiased preselection
of gene set types to be used on the final datasets. Due to the nature of the data, all
datasets contain only 6-10 samples.
1201 from the 314 predicted (Perez-Rueda and Collado-Vides, 2000) regulatory proteins are
currently available.
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In order to see how the tested methods perform on different kinds of datasets,
depending on the number of genes which are critical for the phenotypes, we also
divided the datasets in the N/O datasets into two groups: datasets which contain
a phenotype induced by knockouting some genes (KO datasets) and datasets which
do not contain any such phenotype-class (non-KO datasets). It turns out that all
the datasets in the set N/O which contain knockouted genes originate from the series
GSE6836.
Series id Platform id # phenotypes
GSE6836 GPL199 62
GSE33147 GPL199 30
GSE10160-1 GPL199 9
GSE10160-2 GPL3154 4
GSE35371 GPL3154 20
GSE21869 GPL199 5
GSE17505 GPL199 10
GSE34023* GPL3154 7
GSE7398* GPL199 8
GSE4778 GPL199 4
Table 6.2: List of used gene series. The series marked with * were omitted due their
use in the RegulonDB.
6.2.4 Experimental protocol
The experimental protocol used in this chapter consists of two steps. In the first step,
we pre-select the best performing gene set types—one type from the three types of
operon-based gene sets and one type from the three regulatory-network-based gene
sets. For the pre-selection, we use average accuracy estimated by leave-one-out cross-
validation (LOO CV) on the datasets in the set AUX. Then, in the second step, we
evaluate performance of the pre-selected gene sets on the datasets from the set N/O.
Note that the datasets contained in AUX and N/O are independent as they do not
overlap. The rationale for this two-step procedure is that the available datasets are
insufficient for statistically significant comparison of multiple gene set types. This
is resolved by the two-step procedure because it enables us to evaluate statistical
significance of the results only for the gene sets which are selected in an unbiased way
on a different set of datasets. As a consequence, no overoptimistic bias should be
introduced by our evaluation procedure, but higher statistical power can be achieved
than what we could expect to obtain if, for instance, we compared all gene set types
using the Friedman’s rank-sum test.
All statistical tests performed were based on the one-sided paired Wilcoxon test
(unless stated otherwise). For evaluation of three or more methods to get preference
rank which method behaves better than the others, we use sum of ranks from the
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Friedman’s rank-sum test. This approach is also utilized for a graphic representation
of results.
6.3 Results and discussion
We performed experiments in which we assessed accuracy of classifiers based on the
various gene sets and also of classifiers based on individual genes. We performed ex-
periments using complete feature sets and experiments using feature-selection tech-
niques to select a handful of informative features. The results presented in this section
clearly indicate that carefully defined gene sets do not decrease accuracy and are dis-
tinguishable from their fake version as was the case for gene sets which were previously
studied in literature (Abraham et al., 2010; Mramor et al., 2010; Staiger et al., 2012,
2013). In fact, accuracy is improved in most cases by use of gene sets either alone or
in combination with individual genes in the case when feature selection is used.
6.3.1 Preselection of gene sets on independent data
First, we performed the preselection of the gene set types which should be used in
the next step for statistical evaluation, in order to retain reasonable statistical power
of the tests. Recall that otherwise there would be several gene set types to compare
for both transcriptional-network-based gene sets and for the operon-based gene sets,
which would force us to use tests with significantly less power such as the Friedman’s
rank-sum test. This might be acceptable if the datasets were not so small and high-
dimensional at the same time and if high fraction of them was not trivial in the sense
that most classifiers obtain 100% accuracy on them, which is unfortunately the case
for the available datasets we use.
For the preselection, we used sum of ranks obtained by the classifiers based on
the specified gene set types. The results obtained on the set AUX consisting of 100
datasets are shown in Table 6.3. As the result of this auxiliary experiment, we selected
OPRgs chunks as the representatives of operon-based gene sets and REGgs as the
representatives of transcription-network-based gene sets. Although the differences in
average accuracies in Table 6.3 may seem very small, it is necessary to recall that the
averages are computed over 100 datasets. Moreover, all three methods obtained 100%
accuracy in 56 out of 100 cases for the operon-based gene sets and in 51 out of 100
cases for the transcription-network-based gene sets. This explains why the obtained
differences among average accuracies are rather small.
6.3.2 Classification on complete set of features
We evaluated predictive accuracy of the classifiers based on gene set types (OPRgs
chunks and REGgs) preselected on the set of datasets AUX on the independent set
of 71 non-overlapping datasets (N/O). We compared them against their randomized
(“fake”) versions and against classifiers built on the complete sets of genes. When
comparing against classifiers built on complete sets of genes, we used all genes in the
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gene set type mean accuracy [%] sum of ranks
TUgs 82.17 198.50
OPRgs chunks 83.00 205.50
OPRgs 81.50 196.00
REGgs 82.67 211.50
Strict REGgs 82.50 209.50
TFgs 78.69 179.00
Table 6.3: Preselection results. Table contains results on the the 100 auxiliary
datasets; columns contain mean accuracy and sum of ranks over the datasets, higher
rank indicates better performance. Here, the best ranked units are OPRgs chunks
and REGgs.
case of OPRgs chunks and those genes for which at least one regulatory transcription
factor is known in the case of REGgs. The rationale for this is to provide the same
amount of information to both competing methods under comparison (note that every
gene of Ecoli K12 is associated to an operon which is why we use all genes in the case
of operon-based gene sets).
We compared the results of classifiers based on OPRgs chunks and REGgs gene
sets to the classifiers based on the respective full sets of individual genes. We used
the one-sided paired Wilcoxon test. As a result, we got that classifiers based on both
types of gene sets are significantly better than the classifiers based on all individual
genes (REGgs p = 0.038 and OPRgs chunks p = 0.018). We also compared results
obtained by classifiers based on OPRgs chunks and REGgs gene sets against classi-
fiers based on the respective randomized counterparts of these gene sets. Both OPRgs
chunks and REGgs turned out to be significantly better than their randomized coun-
terparts (REGgs p = 0.019 and OPRgs chunks p = 0.030). It’s also worthy of notice
that, despite only one third of all genes appear in at least one transcription factor,
the performances on the all genes and all transcription-factor-related genes are also
indistinguishable (p = 0.635, two sided test).
At first sight, the obtained results may seem to be in disagreement with the results
obtained by Mramor et al. (2010) or in Chapter 5) where gene-set-based classifiers
which represented the aggregated expression of genes by a single number did not
perform better than classifiers built on the complete set of genes whereas they perform
significantly better in our present work. However, there are two differences between
our approach presented here and the work of Mramor et al. or in the previous
chapter. First, we work with gene expression of bacteria whereas the two mentioned
studies used human gene expression data. Second, the gene sets which we use are
constructed so that the genes in them would be correlated and so that the average
expression of these genes would be correlated also to presence of respective regulatory
proteins in their active form. The gene sets used in the previous studies were based
on pathways from the KEGG database and on gene sets from the GO (GO+KEGG).
In order to check whether the better results which we obtained indeed follow as a
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consequence from higher quality of our gene sets, we performed also experiments
with the gene sets from KEGG and the GO. Classifiers based on these gene sets
turned out to be significantly worse in comparison to classifiers based on all genes
which appear in at least one gene set (p = 0.003) and indistinguishable to their
randomized counterpart (p = 1, two sided test). This suggests that the reason why
gene-set-based techniques did not perform well in some of the previous works is that
the gene sets which they used consisted of genes which were not correlated. One
could still argue that the superiority of OPRgs chunks and REGgs over GO+KEGG
is mainly caused by the fact that the average sizes of OPRgs chunks or REGgs are
small in comparison to average sizes of gene sets in GO+KEGG, however, then we
would expect at least that GO+KEGG would achieve higher predictive accuracy than
their randomized (fake) counterparts, which was not the case. This leads us to believe
that carefully selected gene sets may increase predictive accuracy of machine learning
methods while badly selected gene sets may decrease it substantially.
6.3.3 Classification on selected the top n features
We also evaluated the utility of the operon-based and transcription-factor-based gene
sets in the context of predictive classification where feature selection is used to select
features for the classifier learning phase. First, we performed experiments in which
we evaluated predictive accuracy of SVM classifiers learnt on the features selected
from the complete set of genes as a function of the number of features. The average
accuracies are shown in Figure 6.3 for all datasets in the set N/O, for the KO datasets
(the datasets from N/O where at least one class contains knock-outed genes) and for
the non-KO datasets (datasets with no knock-outed genes). We can see that the
highest accuracy is obtained with just a handful of features (genes) in the case of
KO datasets whereas a bigger number of features is needed to obtain the maximum
accuracy on average in the case of non-KO datasets. This is in accordance with the
reasonable assumption that a change in expression of genes induced by knock-outing
a gene should be detectable either from the expression of the gene itself or from the
expression of just a few genes regulated by the respective knock-outed gene. Since the
phenotype-classes in the non-KO datasets usually correspond to reactions to changes
in the environment, it is also natural to expect that the reaction should often exhibit
itself through change in expression of a bigger number of genes.
We performed experiments in which we used the same protocol with feature sets
consisting entirely of the gene sets (either OPRgs chunks or REGgs) or of a combi-
nation of the gene sets and individual genes (called hybrid OPRgs chunks and hybrid
REGgs, respectively). We also performed these experiments with the gene sets from
GO and KEGG. The results are displayed in Figure 6.4. We can see several trends.
First, addition of individual genes improves accuracy for smaller numbers of selected
features which can be seen from the better performance of hybrid OPRgs chunks and
hybrid REGgs. This could be expected especially in the case of KO datasets where
the gene sets may be sometimes too coarse-grained and the expression of certain indi-
vidual genes may be therefore expected to improve the predictive accuracy. Second,
gene sets alone tend to dominate over individual genes and over the combination of in-
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Figure 6.3: The N/O set of datasets is divided into two subsets, the first, N/O—KO,
contains N/O datasets from the series GSE6836 only, and the second, N/O—non-
KO, contains the rest of the datasets. According the series annotation, only the
series GSE6836 contain samples with knock-outed genes.
dividual genes when the number of selected features is higher. This can be attributed
to the fact that the overall number of our gene sets is smaller than the number of
individual genes and therefore there is a somewhat smaller risk of overfitting stem-
ming from feature selection on a large set of features. Third, the accuracies obtained
by classifiers based on GO and KEGG gene sets tend to be substantially worse than
the accuracies obtained by either the classifiers based on selected individual genes or
selected OPRgs chunks. In the latter case, the OPRgs chunks were constructed only
from genes which were contained in at least one gene set from GO or KEGG in order
to allow fair comparison so that the OPRgs chunks would not use more information
than available to GO+KEGG gene sets. The results for GO+KEGG agree to the
findings reported previously in literature (Tintle et al., 2012). When we compare
them to the results for OPRgs chunks and REGgs gene sets, we can see that what
matters is the quality of the gene sets, i.e., how much genes in the given gene sets are
correlated.
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Figure 6.4: Plots of sum of ranks (left panels) and mean accuracy plots (rights panels)
on different types of datasets. Note: While the mean accuracies in the (a) can be
computed as the average of (b) and (c), this property does not hold for the plots of
sum of ranks.
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(a) Results on N/O datasets.
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(b) Results on N/O—KO subset of datasets.
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(c) Results on N/O—non-KO subset of datasets.
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gene set type N/O N/O—GSE6836 N/O except GSE6836
ORPgs chunks 4-0-5 7-0-2 3-2-4
REGgs 4-0-4 4-0-4 4-0-4
Hybrid ORPgs chunks 7-1-1 8-0-1 5-1-3
Hybrid REGgs 8-0-1 8-1-0 6-0-3
Table 6.4: An overview of performance from the Figure 6.4. Each value in the table
denotes a triplet, higher-equal-lower, with performance of a gene set type against its
baseline.
6.3.4 Correlation of gene sets
Since we believe that the main reasons for the observed good performance of our gene
sets based on operon structure of prokaryotic genomes or on the structure of regulatory
networks are: (i) correlation of the average expression of genes in the gene sets with
the presence of the respective regulatory proteins in their active form in the bacteria
and (ii) the correlation of genes in a gene set. Since the extent to which the first reason
is valid is not directly measurable without expensive experiments, we at least assessed
validity of the second claim. The correlations are generated in the following way. For
the random correlations—without considering any gene set—firstly, we select a gene
expression series (note the samples are in columns and rows are identified by genes),
subsequently, we randomly chose n pairs of rows of the series without replacement,
where n = 5000, and compute n Pearson’s correlation coefficients for the selected
pairs. For the correlations defined on gene sets, the following two-step process on
the same data as above is repeated n times: (i) We randomly select a gene set, s,
with probability corresponding to number of 2-combinations of its size. (ii) Using the
selected gene set, s, we randomly select pair of two distinct genes and use them for
computing their correlation coefficient. In order to avoid bias to small gene sets, we
omit single-gene sets.
On Figure 6.5 are the computed correlations for the two largest series where the
first represents KO datasets and the second non-KO datasets. Both our preferred
gene set types, REGgs and OPRgs chunks, show better than random correlation, but
this is not the case of the GO+KEGG gene sets (Fig. 6.5C) where even smaller gene
sets do not show similar correlation like the REGgs and OPRgs chunks gene set types.
6.4 Conclusions
We evaluated the performance of gene sets based on the structure of transcription-
regulation networks and on the operon structure of bacterial genomes using machine
learning and gene set aggregation. All the gene sets are new in the context of predic-
tive classification. For classification using the all-features scheme, we conclude that
using prior knowledge in the form of gene sets can significantly improve predictive
accuracy. This finding is not in contradiction with the conclusion of the paper by
Mramor et al. (2010) as the gene sets used here differed from the gene sets used by
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Figure 6.5: Correlation histograms (and density estimates) of randomly chosen gene
pairs with and without considering the used gene set types. The KO data are repre-
sented by the series GSE6836 and the non-KO data by the series GSE33147.
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(a) Operon-based gene sets.
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(b) TF-based gene sets.
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(c) GO+KEGG-based gene sets. Note the density estimates on GO+KEGG gene sets
limited to maximally 10, 200, and 500 genes per each gene set).
Mramor et al. When we tested the performance of the set-level method with the same
type of gene sets used by Mramor et al., we obtained worse results than when no gene
sets were used which is in agreement with not only Mramor et al. but also other recent
works (Staiger et al., 2012, 2013). For the feature selection case, we cannot assert
significantly the dominance of the novel gene sets, or the combined versions where
gene sets and individual genes were used together over the baseline due to a very
high variance of accuracy typical for this type of experiment and a very low power of
available statistical tests for the case when we have multiple statistically dependent
points on every plot of sum of ranks. However the hybrid gene sets—despite their
higher susceptibility to overfitting—perform better than individual genes for most of
the points on the plots of sum of ranks.
The main conclusion is that methods based on an aggregation of gene sets are
able to improve predictive accuracy when provided with suitable gene sets. When
inappropriate gene sets are used, e.g., when one uses GO terms or KEGG pathways,
then the accuracy may actually drop significantly. Therefore, we concede Hypothesis
2 when suitable gene set collection is chosen.
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Chapter 7
Software implementation of the
set-level methods
Here we present two public freely available tools for gene-expression data analysis
with prior knowledge. This chapter is organized as follows. Section 7.1 describes an
older tool, XGENE.ORG, and Section 7.2 describes a new tool, miXGENE, which is
currently in development. In the future, the latter tool should also gain most of the
XGENE.ORG functionality.
7.1 XGENE.ORG tool: a basic description
The web application, XGENE.ORG, is a tool for cross-platform cross-genome analysis
of gene expression data with several predefined types of prior knowledge in form of
gene sets collecitons.
7.1.1 Introduction
The tool XGENE.ORG (available at http://xgene.org) is designed particularly for
integration of large volumes of raw gene expression measurements with another huge
body of available genomic information in form of gene set collections. XGENE.ORG
offers additional functionality resulting from a data-fusion strategy based a priori de-
fined gene sets (similar to the described in Section 4). In particular, the main resulting
feature of the present tool is that it enables to analyze gene expression data collected
from heterogeneous platforms in an integrated manner. The heterogeneous platforms
may pertain to different organism species. The significance of this contribution is
at least twofold. First, microarray experiments are costly, often resulting in num-
bers of samples insufficient for reliable modeling. The possibility of systematically
integrating the experimenter’s data with numerous public expression samples coming
from heterogeneous platforms, would obviously help the experimenter. Second, such
integrated analysis provides the principal means to discover biological markers shared
by different-genome species.
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XGENE.ORG explicitly implements various set-level features (working units) and
determines their activity score. The activity of a superior (more abstract) working
unit is calculated from the known (measured) activity of a set of inferior (less general)
working units. For example, it selects all the probesets that are annotated by the
same gene identifier and computes gene activity. Likewise, all the genes whose prod-
ucts act in a single pathway are used to compute pathway activity. XGENE.ORG
works with a various types of working units on different levels of generality, and use
them to perform cross-genome and cross-organism analysis as there are working units
that generalize beyond individual platforms and species. Furthermore, in addition
to standard statistical analyses, it applies machine learning techniques to develop
interpretable models that distinguish among user-defined classes.
Let us exemplify some of the available types of working units. The first type that
enables cross-platform analysis aggregates measurements that share a common GO
term. The second type aggregates measurement units acting in the same biological
pathways formalized by the KEGG database. The third type represents is based on
the notion of the fully coupled flux.
To sum up, analyses and models based solely on measurement units defined by
the individual probesets whose expression is immediately measured by microarrays
suffer from the inherent microarray noise and often fail to identify subtle patterns,
give a large room to overfitting and prove hard to interpret and apply. Genomic prior
knowledge makes it possible to introduce and analyze alternative working units that
avoid the bottlenecks mentioned above and provide improved interpretation power
and statistical significance of analysis results. At the same time, different platforms
and/or species deal with different sets of measurement units that cannot be directly
matched. Consequently, multi-platform analyses cannot be performed without work-
ing units whose meaning is general enough to be defined in each platform and whose
activity can unambiguously be evaluated in each sample independently of its plat-
form type. Working units then serve as markers (or features) to distinguish between
user-supplied sample classes.
7.1.2 System description
The main goal of XGENE.ORG tool is to analyze a wide range of publicly accessible
heterogeneous gene expression samples. The tool provides an interface to search
available measurements whose annotation is relevant to the studied biological topic.
Typically, a set of relevant measurements straddles various microarray platforms and
organisms. There are two principal reasons to allow for their integration (Chapter 4).
The technical reason concerns the sufficiency of sample sets for reliable modeling.
The more platforms accessed, the larger number of samples is at hand. The scientific
reason pertains to the relevance of the outcomes. Combining multi-platform input
data contributes to the generality of any knowledge discovered.
The tool operates in three basic phases:
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1. define sample classes of interest; search and collect existing measurements rep-
resenting these classes,
2. compute the activity scores of various working units with respect to the collected
samples,
3. apply statistical, machine learning and visualization methods to obtain mod-
els distinguishing between the defined classes, with the pre-computed activity
scores of working units acting as sample features.
XGENE.ORG implements this workflow, facilitating all three phases above. The
architecture of the tool is depicted in Figure 7.1. XGENE.ORG integrates data from
several publicly accessible databases.
Regarding the first phase above, our tool provides an interface to the GEO.
XGENE.ORG enables a keyword-based search and filtering of individual gene ex-
pression measurements as illustrated in Fig. 7.2. The interaction with the GEO is
supervised by the user. The measurements are normalized and saved in the internal
format that simplifies subsequent integration of the expression data with data cap-
turing biological process structure (pathways) and relational information (the Gene
ontology).
Secondly, XGENE.ORG accesses the databases that provide prior knowledge re-
quired to define and interpret the predefined set of working unit types (they are
discussed in detail thereunder). The individual microarray platforms are annotated
by the Bioconductor packages (Gentleman et al., 2004). Bioconductor packages also
provide annotations by the GO terms. The prior knowledge on pathways and fluxes
is taken directly from KEGG database. The prior knowledge management is fully
automated and carried out without user interventions. The tool downloads all the
packages and datasets needed to analyze the measurements currently selected by the
user and stores them in the internal representation.
The critical step is to fuse the collected measurements and prior knowledge into
unified cross-platform data subsequently accessed by the statistical and machine
learning tools. Within this fusion, working units are computed across samples taken
from various platforms and organisms. The resulting unified representation consists
of a single matrix in which rows correspond to samples, columns correspond to work-
ing units and the respective matrix cells express the activity of a given unit within
a given sample as a real value. Each working unit subsequently serves as a statisti-
cal variable for tasks such as fold change analysis, or a sample feature for machine
learning algorithms.
Three kinds of analysis results are supported:
• a classifier that estimates the sample class given an expression sample and its
platform label
• a list of working units significantly differentially expressed in classes
• a scatterplot that shows class distribution in a (transformed 2D) space of work-
ing units.
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Figure 7.1: XGENE.ORG architecture
The results are provided to the user in the form of hypertext, including links pointing
to detailed descriptions working units employed in the displayed result.
The interaction with the user who starts a new experiment consists of the following
steps:
1. The user logs to his/her personal account. This account stores the user’s pre-
vious experiments and their results.
2. The user creates a new experiment. The experiment can be entirely new (the
interaction proceeds by the following step) or it can be derived from a previous
experiment (the experiment then inherits the classes and datasets defined earlier
and thus skips the two following steps).
3. The user creates and entitles two or more of sample classes. These classes
contain no measurement samples at this stage.
4. The user fills each of the defined classes with a set of relevant GEO expression
samples. The samples are preselected via keyword-based search and then finely
filtered by the user on the basis of experimental annotations (see Figure 7.2),
5. The user selects (possibly repeatedly) proper working units, platform types and
algorithms and starts the experiment.
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Figure 7.2: XGENE.ORG: collecting relevant samples from NCBI GEO. Clicking on
a sample identifier (‘GSMxxxxx’) opens a detailed description of that sample.
6. The system collects the necessary prior knowledge, computes the working units
defined above and applies the selected algorithms.
7. The computation begins and the user can log out. (S)he are informed by email
as soon as the results are ready to be shown.
8. The user views the results. A result-filter helps user’s orientation if a large
number of result types has been requested in step 5.
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7.1.3 Methods
This section describes the methodological elements of our approach. It gives an
overview of working units and shows the way in which their activity is estimated
and evaluated. It specifies the statistical methods serving to identify differentially
expressed working units. It also gives a summary of currently implemented machine
learning methods.
Working units—types and activity
XGENE.ORG consider two principal knowledge sources in order to define working
units—the GO databaseand the KEGG database. The Bioconductor annotation
packages serve to translate among the identifiers used by the microarray manufactur-
ers (only Affymetrix is supported), and the two mentioned prior knowledge databases.
The widely spread EntrezIds (gene identifiers) introduced by NCBI play the role of
intermediate translation identifiers. The hierarchy of working units as implemented
in XGENE.ORG is shown in Figure 7.3. The ultimate working units correspond to
the measurement units, i.e., the probesets. Their activity in the individual samples
is directly reported in the GEO input files. A single GEO file corresponds to a single
microarray sample, a whole sample is represented by a probeset activity vector. The
set of measured probesets is platform dependent, i.e., the vectors taken form different
platforms cannot be directly matched. The more general units are gradually inferred
from their subordinate units. For example, the list of probesets that are annotated by
the same gene identifier makes up the gene working unit. The list of genes linked to a
pathway node makes up the pathway node working unit. The activity of a pathway is
computed by aggregating the activity of all probesets corresponding to genes which
in turn correspond to nodes contained in the given pathway. Obviously, this mapping
is platform dependent; pathways have different probeset interpretations in different
platforms. At the same time, this mapping is organism dependent and thus we have
to deal with organism orthologs of pathways, like in the Section 4.
The process of computation of KEGG node activity in a sample set that originates
from two different platforms is exactly the same as in Figure 4.2. The only differ-
ence is that XGENE.ORG uses pathways, particularly pathway nodes, for mapping
between different platforms instead of the orthology tables used in the experiments
in Chapter 4.
Analysis algorithms
After the collection of all data needed for a defined experiment, normalization is
conducted separately for each involved platform to consolidate same-platform sam-
ples. Quantile normalization (Bolstad et al., 2003) ensures that the distribution of
expression values across such samples is identical. As a second step, scaling provides
means to consolidate the measurements across multi-platform samples. We subtract
the sample mean from all sample components, and divide them by the standard de-
viation within the sample. As a result, all samples independently of the platform
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Figure 7.3: The hierarchy of working units. An arrow from X to Y denotes that
unit Y refers to a set of X units. This relation is transitive and thus all units can
ultimately be represented as families of probesets.
exhibit zero mean and unit variance. We conduct these steps using the Bioconductor
(Gentleman et al., 2004) software.
After normalization, the most basic type of analysis that may be generated on
user’s request is fold change analysis whose goal is to rank the ability of the individual
working units to distinguish among the user-defined classes. For this sake, we apply
the one-way ANOVA or also implement Kruskal-Wallis test, which is a non-parametric
equivalent of the one-way ANOVA. For the set-level analysis, we implement Global
test (Goeman et al., 2004)
Having a single-tabular representation in which activity of a set of working units is
computed across samples, a wide-scale of machine learning algorithms can be applied.
The most interesting appear to be such algorithms that allow for direct human inter-
pretation of the resulting models and still keep a good predictive power. Specifically,
we included the J48 decision tree learner provided by the machine learning environ-
ment WEKA (Hall et al., 2009). The k-nearest neighbor (kNN) algorithm from the
same environment has also been included.
Finally, principal component analysis (PCA) is used for the purpose of dimen-
sionality reduction in a space of working units with subsequent visualization of sam-
ples (Holter et al., 2000). PCA is known to retain those characteristics of the dataset
that contribute most to its variance. In XGENE.ORG it helps to exhibit class distri-
bution in 2D and visually assess the potential of a set of working units to distinguish
among classes.
7.1.4 Case studies
Here we demonstrate our methodology in two biological case studies. We address
general tasks of tissue type classification. The first experiment focuses on distinct
features of blood-forming (hematopoietic) and supportive (stromal) cellular compart-
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ments in the bone marrow. The second assesses differences in brain, liver and muscle
tissues. Both experiments are of biological significance as they tackle novel chal-
lenges in understanding of cellular behavior: the former in the complex functional
unit termed hematopoietic stem cell niche, where inter-dependent hematopoietic and
stromal cell functions synergize in the blood-forming function of the bone marrow;
the latter in comparison of cell fate determined by the tissue origin from the separate
layers of the embryo: ectoderm (brain), endoderm (liver) and mesoderm (muscle).
While of general character, the chosen tasks are not just random biological exer-
cises as these studies may illuminate cellular functions determined by gene expression
signatures in complex cell system seeded by cell-type-heterogeneous undifferentiated
populations (hematopoietic and stromal stem cells in the cell niche), and in the cell-
type-homogeneous differentiated tissues (brain, liver and muscle), respectively.
The significance tests at gene level identified elevated expression of genes canon-
ical for the specific tissue studied, such as myelin basic protein in brain, isocitrate
dehydrogenase in liver, tropomyosin in muscle and differential expression of integrin
beta 5 inhematopoietic and stromal cell populations of the bone marrow.
The experiments with machine learning algorithms proved that working units ap-
plicable across platforms clearly distinguish among classes in both studies. The result-
ing models are compact, easy to interpret and accurate. Fig. 7.4 exemplifies the appli-
cation of the decision tree learner J48 on the level of FCFs in the brain/liver/muscle
study. The model tested by 10-fold cross-validation reaches the classification accuracy
nearly 98%, it misclassifies 3 out of 131 samples. The tree has only 2 internal nodes
(2 activity tests that put into use two FCFs) and 3 leaves (one leaf per class).
A similar conclusion follows from PCA visualizations (Fig. 7.5). The activity of
working units tends to share the same pattern within classes as well as within the
same platforms or the same laboratories. However, the class pattern is strong enough
to clearly distinguish among classes independently of platform.
The complete overview of results is available via the XGENE.ORG webpage.
7.1.5 Discussion
XGENE.ORG is a web tool for the analysis of gene expression data collected from
heterogeneous (multi-platform) microarray platforms under the presence of genomic
prior knowledge. The integration of multi-platform data is conducted automatically
by using the available genomic prior knowledge to define candidate working units gen-
eral enough to be quantified in any sample regardless of the platform on which it was
measured. The heterogeneous data are transformed into a single-tabular representa-
tion which summarizes the activity of the working units for all the collected samples.
Such a unified representation lends itself to various types of analysis provided by
XGENE.ORG based on statistical or machine learning methods.
The contribution of this tool is at least twofold. First, microarray experiments
are costly, often resulting in numbers of samples insufficient for reliable modeling.
The possibility of systematically integrating the experimenter’s data with numerous
public expression samples coming from heterogeneous platforms, would obviously help
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Figure 7.4: The flux-based cross-platform decision tree for the brain/liver/muscle
study. The tree is very compact, the class is determined by two activity thresholds
on two fluxes, the fluxes are visualized using KEGG pathway maps (in bold).
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Figure 7.5: PCA in the hematopoietic/stromal study. The first subfigure shows
cross-platform PCA in the space of pathways, the second subfigure uses FCFs in-
stead. FCFs seem to better separate the classes (which is also confirmed by a higher
classification accuracy if FCFs are used).
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the experimenter. Second, such integrated analysis provides the principal means to
discover biological markers shared by different-genome species.
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7.2 miGENE—a new extension to XGENE.ORG
Here we describe a new bioinformatic tool which extends functionality of XGENE.ORG.
It is a response to challenges related to new data sources of genetic and epigenetic
data on gene level.
7.2.1 Introduction
In the last 15 years, microarrays have become well established technology. Also
other novel high-throughput technologies emerged lately (e.g., RNA-seq, microRNA
arrays, and methylation arrays). The same progress is present in quality and coverage
of knowledge-related biological databases. Despite this progress, still an integrative
analysis of the data remains a challenge. Here we describe a tool which addresses this
issue.
One of the most critical obstacles in the analysis process dwells in use of the
prior knowledge which is typically not related to the measured transcriptional activ-
ity, but concerns more abstract biological phenomena. This complication consists in
a moderate-only correlation between mRNA and protein levels which is caused by
post-transcriptional and post-translational modifications (Vogel and Marcotte, 2012)
which makes the use of the protein-level knowledge difficult (Staiger et al., 2013).
These modifications not only play an important role in cell development and many
diseases (e.g., Nugent, 2014; Peng et al., 2009) but also negatively affects the use
of prior knowledge which is not directly based on transcriptional regulation interac-
tions (e.g., protein-protein interaction networks) (Staiger et al., 2013). This lack of
correlation can be mitigated if we take into account other data sources; particularly,
microRNA expression, since the small non-coding RNAs (microRNAs) play a role
in translational and post-transcriptional regulation of gene expression and often re-
sult in gene silencing, and epigenetic data measuring level of DNA methylation and
explaining unexpected transcriptional irregularities.
Here we presents the web tool miXGENE freely available at http://mixgene.
felk.cvut.cz/. It is designed mainly for joint enrichment analysis of mRNA, mi-
croRNA and DNA methylation data. miXGENE also contains an interface to the
database repository GEO and some other prior knowledge related databases (the GO,
KEGG, MSigDB, miRWalk (Dweep et al., 2011), miRBase (Kozomara and Griffiths-
Jones, 2011)). miXGENE allows the user to create their own analytic pipeline using
an interactive workflow editor and offers a spectrum of methods designed for data
visualisation and analysis of mRNA, microRNA and DNA methylation profiles.
7.2.2 System description
miXGENE is representative of the mashup technology that fuses data from several
publicly available sources (NCBI raw profiles and platform annotations, R Biocon-
ductor libraries (Gentleman et al., 2004) and MSigDB. The tool (Figure 7.6) can
be split into three parts: (i) graphical user interface (task definition, presentation
of results), (ii) workflow management (task decomposition and its global planning
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in terms of the individual plugins) and (iii) computational plugins (implementation
of the individual analytical methods such as data normalization, feature extraction,
learning of classifiers, etc.). Web interface and storage management are implemented
in the web application framework Django, workflow management is implemented in
JavaScript and the computational plugins are mainly implemented in Python and
R (R Core Team, 2013).
miXGENE as a workflow management system
miXGENE as a workflow management system are a growing area of research (Barker
and Hemert, 2008). The main reasons for deployment of WMSs are: (i) an effort to
make computational biology accessible to researchers who are not expert program-
mers, (ii) to enable tracking of experimental history and offer an easy-to-use tool
for testing different settings, and (iii) the possibility to exchange the scientific work-
flows (Barker and Hemert, 2008). All these reasons are motivated by a goal to improve
reproducibility, transparency and, therefore, mitigating experimental mistakes. There
are many general frameworks or tools (both stand-alone and web-based) designed to
represent bioinformatic or data-analytic workflows; e.g., BioBike (Elhai et al., 2009),
Taverna (Wolstencroft et al., 2013), Galaxy (Goecks et al., 2010) and Anduril (Ovaska
et al., 2010). miXGENE can be seen as a specialized bioinformatics workflow man-
agement system. Despite the fact the mentioned WMSs (mainly the Galaxy) already
implement some tools (several statistical test) and interfaces (GEO) we require, the
WMSs are too general for our purposes. Therefore, in order to facilitate maintenance
(e.g., keeping our system up-to-date and as specific for the joint analysis as possible),
we implemented our own WMS.
With miXGENE, all experiments are built from components called blocks using
interactive workspace. Each block represents one meaningful step in the experiment
e.g., providing a source dataset, creating a machine learning model, visualisation.
Nevertheless, each block usually contains—in contrast to the more general systems
mentioned above—a few atomic activities such as downloading input data, preprocess-
ing and diagnostic visualization in the source dataset providing block. The execution
order is inferred from the data flow defined by binding the corresponding output and
input ports of the consecutive blocks. miXGENE enables the block structured pat-
tern (La Rosa et al., 2011) and it does not allow cycle dependency and conditional
execution.
miXGENE building blocks and types
miXGENE defines two types of blocks: “basic” blocks and meta-blocks where the
latter serve as containers of other blocks or meta-blocks. The meta-blocks generate
their own scope of possible input variables and, therefore, improve simplicity and
clarity of workflows. This structure allows powerful and clear representation of ma-
chine learning workflows. Currently miXGENE enables blocks with the following
functionality: (i) data input (access to gene expression data and knowledge from
local user files or to selected public repositories), (ii) data preprocessing (tools
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(a) Main page of the system.
(b) Interactive workflow editor.
Figure 7.6: miXGENE tool.
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for working with missing data and normalisation), (iii) data manipulation (sim-
ple data concatenation in case of compatible datasets; integrating different datasets,
e.g., from different platforms measuring mRNA expression and joint analysis for data
from mRNA, microRNA and methylation platforms; see Section 7.2.3 for details),
(iv) analysis (various machine learning and statistical methods; see Section 7.2.3
for details), (v) visualization (results in human readable form, e.g., graphs, tables,
textual descriptions of models, (vi) performance evaluation (meta-block) (eval-
uation schemes like k-fold cross validation or leave-one-out cross-validation), (vii)
multiple datasets evaluation (meta-block) (for performing the same experiment
on two or more datasets).
miXGENE operates with predefined complex data types rather than with a com-
bination of atomic types like integer, string, and array. Such an approach allows
a required combination of data and meta-data for the desired level of workflow ab-
straction. E.g., the Expression set type contains gene expression data defined by a
matrix dataset, phenotype description and platform annotation. Meta-data contains
useful information about object content like data provider, used data type, proper-
ties of source tissue, etc. Data content is an object stored in fixed structure. Since
data content may consume a great amount of memory, the complex data types allow
serialization into the storage system.
List of implemented complex data types: (i) expression set (represents gene-
expression data from a micro-array experiment including all necessary information),
(ii) gene set (structure for representation of sets of genes, e.g., GO terms), (iii)
machine learning model (learned model/classifier for the given data), (iv) result
table (generic table in which each row represents features analysed during an ex-
periment and each column represents different properties, metadata section contains
a description of the column properties and working units), (v) array container
(array of objects with the same structure, the cell structure description is stored in
the metadata section).
Workflow construction
The main point of interaction between a user and the system is an experiment
workspace with a block toolbox where the user defines an experimental workflow
and executes it. The user constructs the new experiment from the empty workspace
by adding appropriate blocks from the toolbox. To define data-flow, the user as-
signs input ports to outputs of the appropriate blocks. Then (if needed) the user
sets mandatory or optional block parameters. When all the blocks in the experiment
are configured correctly, the user can either execute each block by hand or run an
automatic execution of the all blocks at the same time. The user will be notified
about experiment’s successful completion or will be pointed to occurred errors. The
interactive nature of the experiment workspace allows the user to add more blocks
anytime and continue the experiment with all the acquired results. Depiction of a
machine-learning experiment based on a comparison of two alternative methods for
analysis of mRNA and microRNA data is available via the miXGENE webpage. The
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Figure 7.7: Workflow schema from the second case study. The first step is data
and knowledge upload. In the nested meta-blocks, different types of data aggregation
techniques are used. This workflow represents a cross-validation performance estimate
of different machine learning algorithms over different data phenotypes (tasks). (From
Gologuzov, 2014)
shown workflow produces an estimate of accuracy of both methods and also final
models based on the mentioned methods.
7.2.3 Methods
This section describes the methodological elements of our approach. The implemented
WMS is primarily designed to support analysis using attribute-value machine-learning
methods. These methods take input in the form of matrix where samples are in
columns and features (e.g., probesets or genes) are in rows; each column contains a
gene expression profile from one sample. In the case of supervised learning methods
there is another vector with an assignment of each sample to a class of samples (e.g.
healthy or cancerous tissue). The unsupervised learning methods do not include such
a vector; instead, it makes its own classification using data properties. As input
data, miXGENE currently supports a few human and mouse mRNA and microRNA
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platforms provided by Affymetrix and Illumina GoldenGate methylation assays. A
complete list of the supported platforms is available on the miXGENE web.
Aggregating methods for knowledge enrichment
The aggregating methods (alternatively set-statistics methods) can incorporate prior
knowledge in the form of gene-sets using a direct transformation which also produces
matrix data representation. For example, there is the pathway p which is represented
as a set of genes g1, g2, . . . , gn and matrix with gene expression profiles where each row
contains GEs for a gene gj for the all samples. The aggregating methods transform
the gene-expression matrix induced by the genes in the pathway p into a row vector
which represents aggregated expressions for all the samples; such a vector is typically
denoted by the name of the geneset p. The current miXGENE version supports the
following methods: simple statistics as mean, median, PCA based transformation,
and SetSig (Mramor et al., 2010). Thanks the flexible representation of workflows,
the miXGENE does not impose any restriction on the gene-sets’ definition; therefore,
it is possible to use these aggregation functions anytime there are appropriate gene-
sets which can define the transformation from the former to the new representation.
Data integration approaches
Integrated analysis of gene expression data from different platforms and
organisms. The integration is based on an assumption that it is generally possible
to transform different data on the same common scale. For the integration of different
MA platforms it can be mapping to the same genes and for different species it can be
in evolutionary conserved elements like orthologous proteins. Generally, any common
functionality describing gene sets like pathways or the GO terms can be used (Holec
et al., 2009a).
Joint analysis of mRNA microRNA and methylation profiles. Presently,
miXGENE supports two joint-analysis approaches. The first one is the “naive” ap-
proach proposed in Lanza et al. (2007) which is implicitly accessible due to the flex-
ibility of the workflow designer tool and power of the machine learning methods. It
joins all of the types of datasets by columns; from the three datasets with mRNA,
microRNA and methylation profiles which are represented by three matrices with
features FmicroRNA, FmicroRNA and Fmethyl the new “joint” dataset contains the set
of features Fjoin = FmicroRNA ∪ FmicroRNA ∪ Fmethyl. The second approach is based
on a correction of mRNA expressions using microRNA expression profiles and known
microRNA targets which describe the regulatory effect of microRNAs on mRNAs.
miXGENE implements two versions of this approach; the substractive and the SVD-
based method, which are suitable only for mRNA and microRNA data (Kle´ma et al.,
2014).
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Other methods
miXGENE also implements other well established and state-of-the-art methods for
analysis on single data with and without prior knowledge and on joint mRNA and
microRNA datasets as referential standards. Different analytical approaches typi-
cally offer definite different solution due to the presence of alternative solutions (e.g.,
marker genes can point not on to disease causing genes but erroneously to genes re-
lated to a consequence of the disease) or unstable nature of the methods (Michiels
et al., 2005). Moreover, the lack of gold standard data makes it impossible to com-
pare alternative methods thoroughly; therefore, there is a need for the referential
methods in order to problem being scrutinized to the depths necessary. For the prior
knowledge-enriched analysis of mRNA expression, miXGENE integrates the global
test (Goeman et al., 2004). As an alternative to the joint analysis methods we have
implemented the algorithm based on generation context specific microRNA regulation
modules based on GO terms (Zhou et al., 2013).
7.2.4 Case studies
Here we demonstrate miXGENE functionality in two biological case studies. A concise
overview of results is available via the miXGENE webpage. The first study follows
experiments from Chapter 6.
The first cas study focused on an evaluation of the hypothesis “gene set aggrega-
tion methods improve predictive accuracy if we use gene sets based on the structure of
transcription regulation networks and on the operon structure of bacterial genomes”
and was conducted solely on mRNA gene expression data. Recent studies reject this
hypothesis for gene sets based on the GO terms and KEGG pathways (Mramor et al.,
2010; Staiger et al., 2013). We evaluated this hypothesis on 71 small microarray GE
datasets measured in the bacteria. The results on the bacterial data indicate that
methods based on aggregation of gene sets are able to improve predictive accuracy
when provided with suitable gene sets. When inappropriate gene sets are used, e.g.,
when one uses GO terms or KEGG pathways, then the accuracy may actually drop
significantly.
In the second case study, we evaluated our novel feature extraction and data inte-
gration method for the accurate and interpretable classification of biological samples
based on their mRNA and microRNA expression profiles. The main idea was to
use the knowledge of microRNA targets and better approximate the actual protein
amount synthesized in the sample. The raw mRNA and microRNA expression fea-
tures become enriched or replaced by new aggregated features that model the mRNA-
microRNA regulation instead. The underlying hypothesis is that “the sample profile
presumably gets closer to the phenotype being predicted”. The proposed subtrac-
tive aggregation method (SubAgg) directly implements a simple mRNA-microRNA
interaction model in which mRNA expression is modified using the expression of
its targeting microRNAs. This method works with the simplifying assumption of
the equal weight of the individual microRNAs suitable for small sample sizes where
learning of their proper weights may lead to overfitting. Its SVD-based modification
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(SVDAgg) enables different subtractive weights for different microRNAs learned by
SVD. The two proposed knowledge-based subtractive methods were compared with
their straightforward counterparts for obtaining the integrated mRNA and microRNA
data through concatenating two respective datasets. We classified germ cell tumors
patients under various experimental settings and compared the concatenation with
SubAgg and SVDAgg. The results suggest that the knowledge-based approaches
dominate the concatenation benchmark, and the features resulting from the mRNA-
microRNA target relation can improve classification performance.
7.2.5 Conclusion
miXGENE represents a web tool for automated learning from heterogeneous genomic
measurements that makes use of prior knowledge. The resulting models and markers
match the actual measurements as well as the relationships among biological entities
recorded in curated biological databases. The contribution of this tool is as follows.
First, it provides the principal means for the user-friendly discovery of dedicated
models in particular domains. Second, it is the platform for assembly, development,
comparison and eventual dissemination of the methods for joint analysis of omics
data. When compared with the traditional learning and statistical tools such as
WEKA, RapidMiner, Orange or R/Bioconductor, it offers web interface with the
possibility to easily fetch NCBI data and implements specific learning methods, cur-
rently SubAgg and SVDAgg proposed in Kle´ma et al. (2014). When compared with
the bioinformatics WMSs such as Galaxy, it is focused on the specific task of learning
from heterogeneous expression data. In particular, it facilitates the access both to the
expression data and prior knowledge on their interaction, it provides specific learning
methods and suggests sample workflows relevant to the given task.
Future work lies in further development and implementation of dedicated integra-
tion tools. We plan to continue with the development of our own methods as well
as to employ the existing state-of-the-art algorithms. At the moment, there are no
integration methods available for methylation and other epigenetic data available in
miXGENE. We intend to improve miXGENE tool itself too, namely its graphical user
interface and visualisation tools that serve for the presentation of results.
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Chapter 8
Conclusions
In this thesis we examined several aspects of the gene expression data analysis in
terms of priori defined gene sets and their impact on predictive performance. This
approach provides more compact and interpretable results than those produced by
traditional methods that rely on individual genes. The potential performance im-
provement rests in a correct feature-space reduction caused by the transformation of
gene-level features into set-level features. Moreover, the analysis of the transformed
data can be accomplished with traditional and well established supervised machine
learning algorithms and offers a natural way to compare the performance of different
methods.
The Conclusion is structured in three sections. Section 8.1 summarizes all the
obtained results. Section 8.2 further discusses some of the salient experimental ob-
servations in light of some recent relevant papers. Section 8.3 indicates possible ways
of future development.
8.1 Results
The core of this work is based on the thorough evaluation of different ratios between
the number of samples and knowledge-enriched features in a large amount of classifi-
cation experiments. Particularly, we evaluated two hypotheses (Hypothesis 1 and 2),
where the first being related to the possibility of integrating observations from hetero-
geneous sources (originating even from different species), and the second addressing
the question of whether gene expression data transformed from the space of genes
into the space of gene sets lead to better results than the original non-transformed
data. The entire evaluation is based on a comparison of predictive accuracies.
Moreover, we developed two publicly available tools, XGENE.ORG and miX-
GENE, where the former is dedicated to cross-platform and cross-species analysis
and the latter provides the complete platform for the integrated analysis of mRNA,
miRNA, and DNA methylation data with prior knowledge.
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8.1.1 Hypothesis 1
To examine the first hypothesis, we demonstrate the integration of multi-platform
gene expression data for predictive classification. When single-platform samples are
rare, integration of related (cross-platform and cross-species) data boosts classification
performance which supports Hypothesis 1 for the limited number of available samples
only. In addition, we explored three ways of defining gene sets, including that based
on the notion of the fully coupled flux representing a trade-off between very specific
genes and general metabolic pathways. In 20 cross-platform classification tasks, we
showed that the gene-set-based representation is useful for combining heterogeneous
gene expression data. This may be for the sake of assembling a larger sample set
or to obtain general biological insights not limited to a particular organism. The
gene set features significantly outperform the gene-oriented ones in small sample sets
(the training sets containing 10% and 20% of available samples), the fluxes keep this
property even for the largest tested sample sets (the training sets containing 50% of
available samples). The pathways and GO terms also give higher predictive accuracies
than the gene-based features, but the significance of this difference cannot be proved
on the selected significance level.
8.1.2 Hypothesis 2
We divided the examination of the second hypothesis into the two specific cases, the
first is the general evaluation on Homo sapiens data using state-of-the-art gene sets
(pathways and GO terms), and the second is performed entirely on Escherichia coli
bacteria and focuses primarily on new, originally designed, gene set collections based
on bacterial transcriptional regulatory networks.
Results on the state-of-the-art gene sets
We have established the following main conclusions by executing various experiments
on 30 gene expression data classification problems.
1. State-of-the-art gene set ranking methods (GSEA, SAM-GS, Global test) per-
form reasonably as feature selectors in the machine learning context in that high
ranking gene sets outperform (i.e., constitute better features for classification
than) those that are low ranking.
2. Genuine curated gene sets from the Molecular Signature Database outperform
randomized gene sets. Smaller gene sets and sets pertaining to chemical and
genetic perturbations were particularly successful.
3. For gene set selection, the Global test (Goeman and Bu¨hlmann, 2007) outper-
forms SAM-GS (Dinu et al., 2007), GSEA (Subramanian et al., 2005) as well
as the generic information gain heuristic (Mitchell, 1997) and the SVM-based
recursive feature elimination approach (Guyon et al., 2002).
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4. For aggregating expressions of set member genes into a unique feature value,
both SVD (Tomfohr et al., 2005) and SetSig (Mramor et al., 2010) outperform
arithmetic averaging (e.g., Holec et al., 2009b).
5. Using the top ten gene sets to construct features results in better classifiers than
using only the single best gene set.
6. The set-level approach using the top ten genuine gene sets as ranked by the
Global test outperforms the baseline gene-level method in which the learning
algorithm is given access to expressions of all measured genes. However, it is
outperformed by the baseline approach if the latter is equipped with a prior
feature selection step.
Conclusion 1 is rather obvious and was essentially meant as a preparatory check.
The first statement of Conclusion 2 is not obvious, since constructing randomized
gene sets in fact corresponds to the machine learning technique of stochastic feature
extraction (Ho, 1998) and as such may itself contribute to learning good classifiers.
Nevertheless, relevant prior knowledge resting in the prior definition of biologically
plausible gene sets contributes further to increasing the predictive accuracy. Conclu-
sions 3 and 4 are probably the most significant for practitioners in set-level predictive
modeling of gene expression as so far there has been no clear guidance for making the
right choice.
Concerning Conclusion 3, the advantages of the Global test were argued in Goe-
man and Bu¨hlmann (2007) but not supported in terms of the predictive power of
the selected gene sets. As for Conclusion 4, the SetSig technique was introduced and
tested in Mramor et al. (2010), appearing superior to both averaging and a PCA-
based method which is conceptually equivalent to the SVD method (Tomfohr et al.,
2005). However, owing to the limited experimental material in Mramor et al. (2010),
the ranking was not confirmed by a statistical test. Here we confirmed the superiority
of SetSig with respect to averaging; however, the difference between the performance
of SetSig and SVD was not significant.
A further remark concerns the aggregation methods mentioned. All three of them
are applicable to any kind of gene set collections, whether these are derived from
pathways, the GO or other sources of prior knowledge. The downside of this generality
is that substantial information available for specific kinds of gene sets is ignored.
Conclusion 5 is not entirely surprising. Relying only on a single gene set entails too
large an information loss and results in classifiers less accurate than those using the
ten best gene sets. Note that in the single gene set case, when aggregation is applied
(SVD, AVG or SetSig), the sample becomes represented by only a single real-valued
feature and learning essentially reduces to finding a threshold value for it. To verify
that more than one gene set should be taken into account, we tested the 10-best-sets
option and indeed it performed better.
A straightforward interpretation of Conclusion 6 is that the set-level framework
is not an instrument for boosting predictive accuracy, and—therefore—we can reject
Hypothesis 2 for the used state-of-the-art gene set collections, data, and methods.
However, set-level classifiers have a value per se, just as set-level units are useful in
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the standard differential analysis of gene expression data. In this light, it is important
that with a suitable choice of techniques, set-level classifiers do achieve an accuracy
competitive with conventional gene-level classifiers.
Results on the originally designed gene sets
We evaluated the performance of gene sets based on the structure of transcription-
regulation networks and on the operon structure of bacterial genomes using machine
learning and gene set aggregation. All the gene sets are new in the context of predic-
tive classification. For classification using the all-features scheme, we conclude that
using prior knowledge in the form of gene sets can significantly improve predictive
accuracy. This finding is not in contradiction with the conclusion of the paper by
Mramor et al. (2010) as the gene sets used here differed from the gene sets used by
Mramor et al. When we tested the performance of the set-level method with the same
type of gene sets used by Mramor et al., we obtained worse results than when no gene
sets were used which is in agreement with not only Mramor et al. but also other recent
works (Staiger et al., 2012, 2013). For the feature selection case, we cannot assert
significantly the dominance of the novel gene sets, or the combined versions where
gene sets and individual genes were used together over the baseline due to a very
high variance of accuracy typical for this type of experiment and a very low power of
available statistical tests for the case when we have multiple statistically dependent
points on every plot of sum of ranks. However the hybrid gene sets—despite their
higher susceptibility to overfitting—perform better than individual genes for most of
the points on the plots of sum of ranks.
The main conclusion is that methods based on an aggregation of gene sets are
able to improve predictive accuracy when provided with suitable gene sets. When
inappropriate gene sets are used, e.g., when one uses GO terms or KEGG pathways,
then the accuracy may actually drop significantly. Therefore, we concede Hypothesis
2 when suitable gene set collection is chosen.
8.1.3 Software implementation of the set-level methods
XGENE
XGENE.ORG is a web tool for the analysis of gene expression data collected from
heterogeneous (multi-platform) microarray platforms under the presence of genomic
prior knowledge. The integration of multi-platform data is conducted automatically
by using the available genomic prior knowledge to define candidate working units gen-
eral enough to be quantified in any sample regardless of the platform on which it was
measured. The heterogeneous data are transformed into a single-tabular representa-
tion which summarizes the activity of the working units for all the collected samples.
Such a unified representation lends itself to various types of analysis provided by
XGENE.ORG based on statistical or machine learning methods. The contribution of
this tool is at least twofold. First, microarray experiments are costly, often resulting in
numbers of samples insufficient for reliable modeling. The possibility of systematically
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integrating the experimenter’s data with numerous public expression samples coming
from heterogeneous platforms, would obviously help the experimenter. Second, such
integrated analysis provides the principal means to discover biological markers shared
by different-genome species.
miXGENE
The web tool miXGENE offers automated learning from heterogeneous genomic mea-
surements that makes use of prior knowledge. The resulting models and markers
match the actual measurements as well as the relationships among biological entities
recorded in curated biological databases. The main contribution of this tool is the
following. First, it provides the principal means for the user-friendly discovery of
dedicated models in particular domains. Second, it is the platform for assembly, de-
velopment, comparison and eventual dissemination of the methods for joint analysis
of “omics” data. When compared with the traditional learning and statistical tools
such as WEKA, RapidMiner, Orange or R/Bioconductor, it offers web interface with
the possibility to easily fetch NCBI data and implements specific learning methods,
currently SubAgg and SVDAgg proposed in Kle´ma et al. (2014). When compared
with the bioinformatics WMSs such as Galaxy, it is focused on the specific task of
learning from heterogeneous expression data. In particular, it facilitates the access
both to the expression data and prior knowledge on their interaction, it provides
specific learning methods and suggests sample workflows relevant to the given task.
8.2 Main observations
Several important observations follow from the previous section. Firstly, the success
of the highly correlated gene set collections (gene sets based on the transcriptional
regulatory network and the fully coupled fluxes in prokaryote and eukaryote organ-
isms data, respectively). By the same token, experimental papers by Staiger et al.
(2012, 2013) clearly demonstrate that there is no difference in performance of methods
using the prior knowledge in the form of genuine and randomly generated protein-
protein interaction networks, which is also theoretically supported by the recently
discovered low correlation between mRNA and protein level (Vogel and Marcotte,
2012). Secondly, the consensus of our results with other studies addressing the set-
level analysis based on the state-of-the-art gene set collections and machine learning
performed on an appropriate number of different datasets (Abraham et al., 2010;
Mramor et al., 2010; Staiger et al., 2012, 2013, or in Chapter 5). Our observation
also supports conclusions that studies performed on a small number of datasets cannot
provide scientifically sound results (Ioannidis, 2005; Jelizarow et al., 2010). Lastly,
the importance of comparison of methods based on the predictive accuracy criterion1
without any biological knowledge, which gives a truly unbiased performance estimate
1Or other appropriate metrics (e.g., the area under ROC curve, the Matthew’s correlation coef-
ficient) when needed.
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criterion; however, general knowledge of the biological phenomenon assessed in the
data is essential.
Despite the number of experiments performed during this study, only a fraction
of the available methods (for feature selection, data aggregation, data integration,
and classification) and their parameters were considered. Complete evaluation of
all major approaches for different data domains exploiting various prior knowledge
remains a challenge due to its combinatorial nature which leads to time-consuming
and human-labor-demanding experiments. A solution to this challenge could lie in a
specially designed experimental environment which could synergically focus the efforts
of many researchers in one place. Important attempts for such an environment are
the Amsterdam Classification and Evaluation Suite (ACES) by Staiger et al. (2013)
and our tool miXGENE (Section 7.2) which combines experimental environment and
a visual language based on workflow editing and is currently under development.
8.3 Future work
The integration of gene expression data and knowledge in the form of gene set collec-
tions can be extended in a qualitative or quantitative way. The first type of extension
consists of using more precise data obtained, e.g., by RNA-seq technology. The latter
type consists of additional data and knowledge source integration (e.g., microRNA,
DNA methylation data, and the complete available transcriptional regulatory knowl-
edge) which allows more precise modeling on the pathway level.
Another direction, in which this work can be extended, consists of a combination
of the current set-level aggregation and feature selection methods in order to take
into consideration the hierarchy of structured gene sets (e.g., the GO structure or
organization of transcription units in operons) in a similar way as it is done in some
statistics based set-level methods (e.g., Goeman and Mansmann, 2008). The ultimate
integration method should take into account the generalization abilities of the set level
(or functional) prior knowledge, and last but not least, include gene level features
during the data modeling process.
The last remark regards the recent strong effort of the scientific community to find
effective ways to merge different modalities of gene expression measurements as well as
related background knowledge. A vast amount of papers comparing different aspects
of the integration have appeared recently but a convincing organized methodology
is still lacking. It remains a challenge to provide suitable tools (e.g., in the form
of language or testing environment) which would connect the different relevant data
sources.
We note here that the tool miXGENE (Section 7.2) reflects our response to the
first and last remarks about possible future work.
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